<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
    <link rel="stylesheet" href="../css/uswds.min.css">
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="css/uswds.min.css">
    <link rel="stylesheet" href="css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title42.html">
                                    Title 42
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/42CFR52.html">Part 52
                                </a><span>&nbsp/&nbsp<span>
                                Sec.  52.9  Additional conditions.
                            </h3>
                            <p class="depth0">The Secretary may with respect to any grant award or class of awards impose additional conditions prior to or at the time of any award when in the Secretary's judgment such conditions are necessary to assure or protect advancement of the approved project, the interests of the public health, or the conservation of grant funds.
[45 FR 12240, Feb. 25, 1980; 45 FR 20096, Mar. 27, 1980]


PART 52a_NATIONAL INSTITUTES OF HEALTH CENTER GRANTS--Table of Contents


Sec.52a.1 To which programs do these regulations apply?52a.2 Definitions.52a.3 Who is eligible to apply?52a.4 What information must each application contain?52a.5 How will NIH evaluate applications?52a.6 Information about grant awards.52a.7 For what purposes may a grantee spend grant funds?52a.8 Other HHS regulations and policies that apply.52a.9 Additional conditions.</p><p class="depth0">Authority: 42 U.S.C. 216, 284g, 285a-6(c)(1)(E), 285a-7(c)(1)(G), 285b-4, 285c-5, 285c-8, 285d-6, 285e-2, 285e-3, 285e-10a, 285f-1, 285g-5, 285g-7, 285g-9, 285m-3, 285o-2, 286a-7(c)(1)(G), 287c-32(c), 300cc-16.</p><p class="depth0">Source: 57 FR 61006, Dec. 23, 1992, unless otherwise noted.


Sec.  52a.1  To which programs do these regulations apply?</p><p class="depth0"><em>(a)</em> The regulations of this part apply to grants by the National Institutes of Health and its organizational components to support the planning, establishment, expansion, and operation of research and demonstration and/or multipurpose centers in health fields described in this paragraph. Specifically, these regulations apply to:</p><p class="depth0"><em>(1)</em> National Institute of Mental Health centers of excellence with respect to research on autism, as authorized by section 409C of the Act (42 U.S.C. 284g);</p><p class="depth0"><em>(2)</em> National cancer research and demonstration centers (including payments for construction), as authorized by section 414 of the Act (42 U.S.C. 285a-3);</p><p class="depth0"><em>(3)</em> National cancer research and demonstration centers with respect to breast cancer, as authorized by section 417 of the Act (42 U.S.C. 285a-6);</p><p class="depth0"><em>(4)</em> National cancer and demonstration centers with respect to prostate cancer, as authorized by section 417A of the Act (42 U.S.C. 285a-7);</p><p class="depth0"><em>(5)</em> National research and demonstration centers for heart, blood vessel, lung, and blood diseases, sickle cell anemia, blood resources, and pediatric cardiovascular diseases (including payments for construction), as authorized by section 422 of the Act (42 U.S.C. 485b-4);</p><p class="depth0"><em>(6)</em> Research and training centers (including diabetes mellitus, and digestive, endocrine, metabolic, kidney and urologic diseases), as authorized by section 431 of the Act (42 U.S.C. 285c-5);</p><p class="depth0"><em>(7)</em> Research and training centers regarding nutritional disorders, as authorized by section 434 of the Act (42 U.S.C. 285c-8);</p><p class="depth0"><em>(8)</em> Multipurpose arthritis and musculoskeletal diseases centers (including payments for alteration, but not construction), as authorized by section 441 of the Act (42 U.S.C. 285d-6);</p><p class="depth0"><em>(9)</em> Alzheimer's disease centers, as authorized by section 445 of the Act (42 U.S.C. 285e-2);</p><p class="depth0"><em>(10)</em> Claude D. Peppers Older Americans Independence Centers, as authorized by section 445A of the Act (42 U.S.C. 285e-3);</p><p class="depth0"><em>(11)</em> Centers of excellence in Alzheimer's disease research and treatment, as authorized by section 445I of the Act (42 U.S.C. 285e-10a);</p><p class="depth0"><em>(12)</em> Research centers regarding chronic fatigue syndrome, as authorized by section 447 of the Act (42 U.S.C. 285f-1);</p><p class="depth0"><em>(13)</em> Research centers with respect to contraception and infertility, as authorized by section 452A of the Act (42 U.S.C. 285g-5);</p><p class="depth0"><em>(14)</em> Child health research centers, as authorized by section 452C of the Act (42 U.S.C. 285g-7);</p><p class="depth0"><em>(15)</em> Fragile X research centers, as authorized by 452E of the Act (42 U.S.C. 285g-9);</p><p class="depth0"><em>(16)</em> Multipurpose deafness and other communication disorders centers, as authorized by section 464C of the Act (42 U.S.C. 285m-3);</p><p class="depth0"><em>(17)</em> National drug abuse research centers, as authorized by section 464N of the Act (42 U.S.C. 285o-2);</p><p class="depth0"><em>(18)</em> Centers of excellence in biomedical and behavioral research training for individuals who are members of minority health disparity populations or other health disparity populations, as authorized by section 485F of the Act (42 U.S.C. 287c-32); and</p><p class="depth0"><em>(19)</em> Centers for acquired immunodeficiency syndrome (AIDS) research, as authorized by section 2316 of the Act (42 U.S.C. 300cc-16).</p><p class="depth0"><em>(b)</em> This part does not apply to:</p><p class="depth0"><em>(1)</em> Grants for construction (see 42 CFR part 52b), except as noted in paragraph (a) of this section;</p><p class="depth0"><em>(2)</em> Grants covered by 42 CFR part 52 (grants for research projects); or</p><p class="depth0"><em>(3)</em> Grants for general research support under section 301(a)(3) of the Act (42 U.S.C. 241(a)(3)).</p><p class="depth0"><em>(c)</em> This part also applies to cooperative agreements made to support the centers specified in paragraph (a) of this section. When a reference is made in this part to ``grants,'' the reference shall include ``cooperative agreements.''
[61 FR 55108, Oct. 24, 1996, as amended at 68 FR 69621, Dec. 15, 2003]


Sec.  52a.2  Definitions.</p><p class="depth0">As used in this part:</p><p class="depth0">Act means the Public Health Services Act, as amended (42 U.S.C. 201 et seq.).</p><p class="depth0">Center means:</p><p class="depth0"><em>(a)</em> For purposes of grants authorized by section 409C of the Act, a public or nonprofit private entity which provides for planning and conducting basic and clinical research into the cause, diagnosis, early detection, prevention, control, and treatment of autism, including the fields of developmental neurobiology, genetics, and psychopharmacology;</p><p class="depth0"><em>(b)</em> For purposes of grants authorized by section 414 of the Act, an agency or institution which provides for planning and conducting basic and clinical research into, training in, and demonstration of advanced diagnostic, control, prevention and treatment methods for cancer;</p><p class="depth0"><em>(c)</em> For purposes of grants authorized by section 417 of the Act, an agency or institution which provides for planning and conducting basic, clinical, epidemiological, psychological, prevention and treatment research and related activities on breast cancer;</p><p class="depth0"><em>(d)</em> For purposes of grants authorized by section 417A of the Act, an agency or institution which provides for planning and conducting basic, clinical, and epidemiological, psychosocial, prevention and control, treatment, research, and related activities on prostate cancer;</p><p class="depth0"><em>(e)</em> For purposes of grants authorized by section 422 of the Act, an agency or institution which provides for planning and basic and clinical research into, training in, and demonstration of, management of blood resources and advanced diagnostic, prevention, and treatment methods (including emergency services) for heart, blood vessel, lung, or blood diseases including sickle cell anemia;</p><p class="depth0"><em>(f)</em> For purposes of grants authorized by section 431 of the Act, a single institution or a consortium of cooperating institutions, which conducts research, training, information programs, epidemiological studies, data collection activities and development of model programs in diabetes mellitus and related endocrine and metabolic diseases;</p><p class="depth0"><em>(g)</em> For purposes of grants authorized by section 434 of the Act, a single institution or a consortium of cooperating institutions which conducts basic and clinical research, training, and information programs in nutritional disorders, including obesity;</p><p class="depth0"><em>(h)</em> For purposes of grants authorized by section 441 of the Act, a facility which conducts basic and clinical research into arthritis and musculosketal diseases; and orthopedic procedures, training, and information programs for the health community and the general public;</p><p class="depth0"><em>(i)</em> For purposes of grants authorized by section 445 of the Act, a public or private nonprofit entity (including university medical centers) which conducts basic and clinical research (including multidisciplinary research) into, training in, and demonstration of advanced diagnostic, prevention, and treatment methods for Alzheimer's disease;</p><p class="depth0"><em>(j)</em> For purposes of grants authorized by section 445A of the Act, a single public or private nonprofit institution or entity or a consortium of cooperating institutions or entities which conducts research into the aging processes and into the diagnosis and treatment of diseases, disorders, and complications related to aging, including menopause, which research includes research on such treatments, and on medical devices and other medical interventions regarding such diseases, disorders, and complications, that can assist individuals in avoiding institutionalization and prolonged hospitalization and in otherwise increasing the independence of the individuals.</p><p class="depth0"><em>(k)</em> For the purposes of section 445I of the Act, a single institution or consortium of cooperating institutions which conducts basic and clinical research on Alzheimer's disease.</p><p class="depth0"><em>(l)</em> For purposes of grants authorized by section 447 of the Act, a single institution or consortium of cooperating institutions which conducts basic and clinical research on chronic fatigue syndrome;</p><p class="depth0"><em>(m)</em> For purposes of grants authorized by section 452A of the Act, a single institution or consortium of cooperating institutions which conducts clinical and other applied research, training programs, continuing education programs, and information programs with respect to methods of contraception, and infertility;</p><p class="depth0"><em>(n)</em> For purposes of grants authorized by section 452C of the Act, an agency or institution which conducts research with respect to child health, and gives priority to the expeditious transfer of advances from basic science to clinical applications and improving the care of infants and children;</p><p class="depth0"><em>(o)</em> For purposes of grants authorized by section 452E of the Act, a single institution or a consortium of cooperating institutions which conducts research for the purposes of improving the diagnosis and treatment of, and finding the cure for, fragile X;</p><p class="depth0"><em>(p)</em> For purposes of grants authorized by section 464C of the Act, a single institution or a consortium of cooperating institutions which conducts basic and clinical research into, training in, information and continuing education programs for the health community and the general public about, and demonstration of, advanced diagnostic, prevention, and treatment methods for disorders of hearing and other communication processes and complications resulting from these disorders;</p><p class="depth0"><em>(q)</em> For purposes of grants authorized by section 464N of the Act, institutions designated as National Drug Abuse Research Centers for interdisciplinary research relating to drug abuse and other biomedical, behavioral, and social issues related to drug abuse;</p><p class="depth0"><em>(r)</em> For purposes of grants authorized by section 485F of the Act, a biomedical or behavioral research institution or consortia that:</p><p class="depth0"><em>(1)</em> Have a significant number of members of minority health disparity populations or other health disparity populations enrolled as students in the institution (including individuals accepted for enrollment in the institution);</p><p class="depth0"><em>(2)</em> Have been effective in assisting such students of the institution to complete the program of education or training and receive the degree involved;</p><p class="depth0"><em>(3)</em> Have made significant efforts to recruit minority students to enroll in and graduate from the institution, which may include providing means-tested scholarships and other financial assistance as appropriate; and</p><p class="depth0"><em>(4)</em> Have made significant recruitment efforts to increase the number of minority or other members of health disparity populations serving in faculty or administrative positions at the institution; or</p><p class="depth0"><em>(s)</em> For the purposes of grants authorized in section 2316 of the Act, an entity for basic and clinical research into, and training in, advanced diagnostic, prevention, and treatment methods for

acquired immunodeficiency syndrome (AIDS).</p><p class="depth0">Director means the Director of NIH or the organizational component authorized to award grants to support centers under this part.</p><p class="depth0">Grant(s) means, unless the context otherwise requires, an award of funds to support a center authorized under Sec.  52a.1. The term includes cooperative agreement(s).</p><p class="depth0">NIH means the National Institutes of Health and its organizational components that award grants.</p><p class="depth0">Nonprofit as applied to any agency or institution means an agency or institution which is a corporation or an association, no part of the net earnings of which inures or may lawfully inure to the benefit of any private shareholder or individual.</p><p class="depth0">Project period means the period of time, from one to five years, specified in the notice of grant award that the NIH or the awarding component intends to support a proposed center without requiring the center to recompete for funds.
[57 FR 61006, Dec. 23, 1992, as amended at 61 FR 55108, Oct. 24, 1996; 68 FR 69621, Dec. 15, 2003]


Sec.  52a.3  Who is eligible to apply?</p><p class="depth0"><em>(a)</em> Any public or private nonprofit agency, institution, or consortium of agencies is eligible to apply for a grant under sections 409C, 414, 417, 417A, 422, 445, 445A, 445I, 447, 452A, and 2316 of the Act.</p><p class="depth0"><em>(b)</em> Any public or private nonprofit or for-profit agency, institution, or consortium of agencies is eligible to apply for a grant under sections 428, 431, 434, 441, 452C, 452E, 464C, 464J, 464N, and 485F of the Act.</p><p class="depth0"><em>(c)</em> Any applicant under this part must be located in a State, the District of Columbia, Puerto Rico, the Virgin Islands, the Canal Zone, Guam, American Samoa, or the successor States of the Trust Territory of the Pacific Islands (the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau).
[57 FR 61006, Dec. 23, 1992, as amended at 61 FR 55109, Oct. 24, 1996; 68 FR 69622, Dec. 15, 2003]


Sec.  52a.4  What information must each application contain?</p><p class="depth0">Each application under this part must include detailed information as to the following:</p><p class="depth0"><em>(a)</em> The personnel, facilities, and other resources available to the applicant with which to initiate and maintain the proposed center grants program;</p><p class="depth0"><em>(b)</em> Any research, training, demonstration, or information dissemination activities in which the applicant is currently engaged; the sources of funding for these activities; and the relevance of these activities to the proposed center grants program;</p><p class="depth0"><em>(c)</em> Proposed research, training, demonstration, and information dissemination activities;</p><p class="depth0"><em>(d)</em> The proposed organizational structure of the center and the relationship of the proposed center to the applicant organization(s);</p><p class="depth0"><em>(e)</em> The names and qualifications of the center director and key staff members who would be responsible for conducting the proposed activities;</p><p class="depth0"><em>(f)</em> Proposed methods for monitoring and evaluating individual activities and the overall center program;</p><p class="depth0"><em>(g)</em> Proposed methods for coordinating the center's activities, where appropriate, with similar efforts by other public and private organizations;</p><p class="depth0"><em>(h)</em> The availability of any community resources necessary to carry out proposed activities; and</p><p class="depth0"><em>(i)</em> Efforts to be made to generate and collect income from sources other than NIH to be used to further the purposes of the center program. NIH encourages these efforts. Income may include, but is not limited to, that generated from the sale or rental of products or services produced by grant-supported activities, such as laboratory tests, computer time, and payments received from patients or third parties, where appropriate (the disposition of grant-related income is governed by 45 CFR 74.40 through 74.47 and 45 CFR 92.25);</p><p class="depth0"><em>(j)</em> The proposed budget for the center and a justification for the amount of the grant funds requested; and</p><p class="depth0"><em>(k)</em> Any other information that the Director of the awarding institute may request.
(Approved under OMB Control Number 0925-0001)


Sec.  52a.5  How will NIH evaluate applications?</p><p class="depth0"><em>(a)</em> NIH considers the following in evaluating Center grant applications:</p><p class="depth0"><em>(1)</em> The scientific and technical merit of the proposed program;</p><p class="depth0"><em>(2)</em> The qualifications and experience of the center director and other key personnel;</p><p class="depth0"><em>(3)</em> The statutory and program purposes to be accomplished;</p><p class="depth0"><em>(4)</em> The extent to which the various components of the proposed program would be coordinated into one multi-disciplinary effort within the center;</p><p class="depth0"><em>(5)</em> The extent to which the center's activities would be coordinated with similar efforts by other organizations;</p><p class="depth0"><em>(6)</em> The administrative and managerial capability of the applicant;</p><p class="depth0"><em>(7)</em> The reasonableness of the proposed budget in relation to the proposed program; and</p><p class="depth0"><em>(8)</em> Other factors which the awarding institute, center, or division considers appropriate in light of its particular statutory mission.</p><p class="depth0"><em>(b)</em> Where required by statute or NIH policy, applications are reviewed by appropriate national advisory councils or boards before awards are made. NIH grants may be awarded generally only after approval recommendations from both appropriate scientific peer review groups and national advisory councils or boards.


Sec.  52a.6  Information about grant awards.</p><p class="depth0"><em>(a)</em> The notice of grant award specifies how long NIH intends to support the project without requiring the project to recompete for funds. This period, called the project period, will usually be for 1-5 years.</p><p class="depth0"><em>(b)</em> Generally, the grant will initially be for one year, and subsequent continuation awards will also be for one year at a time. A grantee must submit a separate application to have the support continued for each subsequent year. Decisions regarding continuation awards and the funding level of such awards will be made after consideration of such factors as the grantee's progress and management practices, and the availability of funds. In all cases, continuation awards require a determination by the NIH that continued funding is in the best interest of the Federal Government.</p><p class="depth0"><em>(c)</em> Neither the approval of any application, nor the award of any grant commits or obligates the Federal Government in any way to make any additional, supplemental, continuation, or other award with respect to any approved application or portion of an approved application.
(Approved under OMB Control Number 0925-0001)


Sec.  52a.7  For what purposes may a grantee spend grant funds?</p><p class="depth0">A grantee shall spend funds it receives under this part solely in accordance with the approved application and budget, the authorizing legislation, the regulations of this part, the terms and conditions of the award, and the applicable cost principles prescribed in 45 CFR 74.27.
[61 FR 55109, Oct. 24, 1996]


Sec.  52a.8  Other HHS regulations and policies that apply.</p><p class="depth0">Several other regulations and policies apply to this part. These include, but are not necessarily limited to:
42 CFR part 50, Subpart A--Responsibilities of PHS awardee and applicant institutions for dealing with and reporting possible misconduct in science42 CFR part 50, Subpart D--Public Health Service grant appeals procedures42 CFR part 50, subpart F--Responsibility of applicants for promoting objectivity in research for which PHS funding is sought45 CFR part 16--Procedures of the Departmental Grant Appeals Board45 CFR part 46--Protection of human subjects45 CFR part 74--Uniform administrative requirements for awards and subawards to institutions of higher education, hospitals, other nonprofit organizations, and commercial organizations; and certain grants and agreements with states, local governments and Indian tribal governments45 CFR part 75--Informal grant appeals procedures

45 CFR part 76--Governmentwide debarment and suspension (nonprocurement) and governmentwide requirements for drug-free workplace (grants)45 CFR part 80--Nondiscrimination under programs receiving Federal assistance through the Department of Health and Human Services--Effectuation of Title VI of the Civil Rights Act of 196445 CFR part 81--Practice and procedure for hearings under part 80 of this title45 CFR part 84--Nondiscrimination on the basis of handicap in programs and activities receiving or benefiting from Federal financial assistance45 CFR part 86--Nondiscrimination on the basis of sex in education programs and activities receiving or benefiting from Federal financial assistance45 CFR part 91--Nondiscrimination on the basis of age in HHS programs or activities receiving Federal financial assistance45 CFR part 92--Uniform administrative requirements for grants and cooperative agreements to State and local governments45 CFR part 93--New restrictions on lobbying59 FR 14508 (March 28, 1994)--NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research.</p><p class="depth0">Note: This policy is subject to change, and interested persons should contact the Office of Research on Women's Health, NIH, Room 201, MSC 0161, BETHESDA, MD 20892-0601 (301-402-1770; not a toll-free number) to obtain references to the current version and any amendments.
59 FR 34496 (July 5, 1994)--NIH Guidelines for Research Involving Recombinant DNA Molecules.</p><p class="depth0">Note: This policy is subject to change, and interested persons should contact the Office of Recombinant DNA Activities, NIH, Suite 323, 6000 Executive Boulevard, MSA 7010, BETHESDA, MD 20892-7010 (301-496-9838; not a toll-free number) to obtain references to the current version and any amendments.
Public Health Service Policy on Humane Care and Use of Laboratory Animals, Office of Laboratory Animal Welfare, Office of Extramural Research, NIH (Revised September 1986).</p><p class="depth0">Note: This policy is subject to change, and interested persons should contact the Office of Laboratory Animal Welfare, Office of Extramural Research, NIH, Rockledge 1, 6705 Rockledge Drive, Bethesda, Maryland 20817, telephone 301-594-2382 (not a toll-free number) to obtain references to the current version and any amendments.
[57 FR 61006, Dec. 23, 1992, as amended at 61 FR 55109, Oct. 24, 1996; 68 FR 69622, Dec. 15, 2003]


Sec.  52a.9  Additional conditions.</p><p class="depth0">The Director may, with respect to any grant award, impose additional conditions prior to or at the time of any award when in the Director's judgment the conditions are necessary to assure the carrying out of the purposes of the award, the interests of the public health, or the conservation of grant funds.
[61 FR 55110, Oct. 24, 1996]


PART 52b_NATIONAL INSTITUTES OF HEALTH CONSTRUCTION GRANTS--Table of Contents


Sec.52b.1 To what programs do these regulations apply?52b.2 Definitions.52b.3 Who is eligible to apply?52b.4 How to apply.52b.5 How will NIH evaluate applications?52b.6 What is the rate of federal financial participation?52b.7 How is the grantee obligated to use the facility?52b.8 How will NIH monitor the use of facilities constructed with</p><p class="depth0">federal funds?52b.9 What is the right of the United States to recover federal funds</p><p class="depth0">when facilities are not used for research or are transferred?52b.10 What are the terms and conditions of awards?52b.11 What are the requirements for acquisition and modernization of</p><p class="depth0">existing facilities?52b.12 What are the minimum requirements of construction and equipment?52b.13 Additional conditions.52b.14 Other federal laws, regulations, executive orders, and policies</p><p class="depth0">that apply.</p><p class="depth0">Authority: 42 U.S.C. 216, 285a-2, 285a-3, 285b-3, 285b-4, 285d-6, 285i, 285m-3, 285o-4, 287a-2, 287a-3, 300cc-41.</p><p class="depth0">Source: 64 FR 63722, Nov. 22, 1999, unless otherwise noted.


Sec.  52b.1  To what programs do these regulations apply?</p><p class="depth0"><em>(a)</em> General. Except as provided in paragraph (c) of this section, this part applies to all grants awarded by NIH and its components for construction of new buildings and the alteration, renovation, remodeling, improvement, expansion, and repair of existing buildings, including the provision of equipment necessary to make the building (or applicable part of the building)

suitable for the purpose for which it was constructed.</p><p class="depth0"><em>(b)</em> Specific programs covered. From time to time the Director may publish a list of the construction grant programs covered by this part. The list is for informational purposes only and is not intended to restrict the statement of applicability in paragraph (a) of this section. In addition, information on particular construction grant programs, including applications and instructions, may be obtained from the component of NIH that administers the program.</p><p class="depth0"><em>(c)</em> Specific programs excluded. The regulations of this part do not apply to minor alterations, renovations, or repairs funded under a research project grant (see part 52 of this chapter) or alterations or renovations funded under an NIH center grant (see part 52a of this chapter).


Sec.  52b.2  Definitions.</p><p class="depth0">As used in this part:</p><p class="depth0">Act means the Public Health Service Act, as amended (42 U.S.C. 201 et seq.).</p><p class="depth0">Construction means the construction of new buildings or the modernization of, or the completion of shell space in, existing buildings (including the installation of fixed equipment), but excluding the cost of land acquisition and off-site improvements.</p><p class="depth0">Construction grant means funds awarded for construction in accordance with the applicable provisions of the Act and this part.</p><p class="depth0">Director means the Director of NIH or the director of an NIH national research institute, center, or other component of NIH, authorized to award grants for construction under the applicable provisions of the Act, and any official to whom the authority involved is delegated.</p><p class="depth0">Federal share with respect to any construction project means the proportion, expressed as a percentage, of the cost of a project to be paid by a grant award under the Act.</p><p class="depth0">HHS, DHHS, and Department mean the Department of Health and Human Services.</p><p class="depth0">Institute means any national research institute, center, or other agency of the National Institutes of Health.</p><p class="depth0">Modernization means the alteration, renovation, remodeling, improvement, expansion, and/or repair of existing buildings and the provision of equipment necessary to make the building suitable for use for the purposes of the particular program.</p><p class="depth0">NIH means the National Institutes of Health and its organizational components that award construction grants.</p><p class="depth0">Nonprofit as applied to any agency or institution means an agency or institution which is a corporation or an association, no part of the net earnings of which inures or may lawfully inure to the benefit of any private shareholder or individual.</p><p class="depth0">Project means the particular construction activity which is supported by a grant under this part.</p><p class="depth0">Secretary means the Secretary of Health and Human Services and any official to whom the authority involved is delegated.


Sec.  52b.3  Who is eligible to apply?</p><p class="depth0">In order to be eligible for a construction grant under this part, the applicant must:</p><p class="depth0"><em>(a)</em> Be a public or private nonprofit agency or institution;</p><p class="depth0"><em>(b)</em> Be located in a state, the District of Columbia, Puerto Rico, the Virgin Islands, the Canal Zone, Guam, American Samoa, or the successor states of the Trust Territory of the Pacific Islands (the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau); and</p><p class="depth0"><em>(c)</em> Meet any additional eligibility criteria specified in the applicable provisions of the Act.


Sec.  52b.4  How to apply.</p><p class="depth0">Applications for construction grants under this part shall be made at the times and in the form and manner as the Secretary may prescribe.


Sec.  52b.5  How will NIH evaluate applications?</p><p class="depth0"><em>(a)</em> In evaluating and approving applications for construction grants under this part, the Director shall take into account, among other pertinent factors, the following:</p><p class="depth0"><em>(1)</em> The priority score assigned to the application by an NIH peer review

group as described in paragraph (b) of this section;</p><p class="depth0"><em>(2)</em> The relevance of the project for which construction is proposed to the objectives and priorities of the particular program authorized by the Act;</p><p class="depth0"><em>(3)</em> The scientific merit of the research activities that will be carried out in the proposed facility;</p><p class="depth0"><em>(4)</em> The scientific or professional standing or reputation of the applicant and of its existing or proposed officers and research staff;</p><p class="depth0"><em>(5)</em> The availability, by affiliation or other association, of other scientific or health personnel and facilities to the extent necessary to carry out effectively the program proposed for the facility, including the adequacy of an acceptable biohazard control and containment program when warranted;</p><p class="depth0"><em>(6)</em> The need for the facility and its total effects on similar or related facilities in the locale, and the need for appropriate geographic distribution of similar facilities; and</p><p class="depth0"><em>(7)</em> The financial need of the applicant.</p><p class="depth0"><em>(b)</em> The priority score of the application shall be based, among other pertinent factors, on the following criteria:</p><p class="depth0"><em>(1)</em> The scientific merit of the total program and its component parts to be carried out in the facility;</p><p class="depth0"><em>(2)</em> The administrative and leadership capabilities of the applicant's officers and staff;</p><p class="depth0"><em>(3)</em> The organization of the applicant's research program and its relationship with the applicant's overall research programs;</p><p class="depth0"><em>(4)</em> The anticipated effect of the project on other relevant research programs and facilities in the geographic area, and nationwide;</p><p class="depth0"><em>(5)</em> The need for the project or additional space; and</p><p class="depth0"><em>(6)</em> The project cost and design.


Sec.  52b.6  What is the rate of federal financial participation?</p><p class="depth0"><em>(a)</em> Unless otherwise specified by statute, the rate of federal financial participation in a construction project supported by a grant under this part shall not be more than 50 percent of the necessary allowable costs of construction as determined by the Director, except that when the Director finds good cause for waiving this limitation, the amount of the construction grant may be more than 50 percent of the necessary allowable costs of construction.</p><p class="depth0"><em>(b)</em> Subject to paragraph (a) of this section, the Director shall set the actual rate of federal financial participation in the necessary allowable costs of construction, taking into consideration the most effective use of available federal funds to further the purposes of the applicable provisions of the Act.


Sec.  52b.7  How is the grantee obligated to use the facility?</p><p class="depth0"><em>(a)</em> The grantee shall use the facility (or that portion of the facility supported by a grant under this part) for its originally authorized purpose so long as needed for that purpose, or other period prescribed by statute, unless the grantee obtains advance approval from the Director, in the form and manner as the Director may prescribe, to use the facility for another purpose. Use for other purposes shall be limited as prescribed in Sec.  52b.9(c)(2).</p><p class="depth0"><em>(b)</em> The Director, in determining whether to approve an alternative use of the facility, shall take into consideration the extent to which:</p><p class="depth0"><em>(1)</em> The facility will be used by the grantee or other owner for a purpose described in Sec.  52b.9(c)(2); or</p><p class="depth0"><em>(2)</em> There are reasonable assurances that alternative facilities not previously used for NIH supported research will be utilized to carry out the original purpose as prescribed in Sec.  52b.9(c)(1).</p><p class="depth0"><em>(c)</em> Sale or transfer. In the form and manner as the Director may prescribe, the grantee may request the Director's approval to sell the facility or transfer title to a third party eligible under Sec.  52b.3 for continued use of the facility for an authorized purpose in accordance with paragraphs (a) and (b) of this section. If approval is permissible under the Act or other federal statute and is granted, the terms of the transfer shall provide that the transferee shall assume all the rights and obligations of the transferor set forth in 45 CFR part 74, the regulations of this part, and the other terms and conditions of the grant.



Sec.  52b.8  How will NIH monitor the use of facilities constructed with federal funds?</p><p class="depth0">NIH may monitor the use of each facility constructed with funds awarded under this part to ensure its continued use for the originally authorized research purpose, by means of reviewing periodic facility use certifications or reports, site visits, and other appropriate means.


Sec.  52b.9  What is the right of the United States to recover Federal funds when facilities are not used for research or are transferred?</p><p class="depth0"><em>(a)</em> If the grantee plans to cease using the facility for the particular biomedical research or training purposes for which it was constructed as required by Sec.  52b.7 (or alternate use authorized under Sec.  52b.7(a) or paragraph (c) of this section), or the grantee decides to sell or transfer title to an entity ineligible for a grant under Sec.  52b.3, the grantee shall request disposition instructions from NIH in the form and manner as the Director may prescribe. Those instructions shall provide for one of the following alternatives:</p><p class="depth0"><em>(1)</em> The facility may be sold and the grantee or transferee shall pay to the United States an amount computed by multiplying the federal share of the facility times the proceeds from the sale (after deducting the actual and reasonable selling and fix-up expenses, if any, from the sales proceeds). The sales procedures must provide for competition to the extent practicable, and be designed to provide the highest possible return;</p><p class="depth0"><em>(2)</em> The grantee may retain title and shall pay to the United States an amount computed by multiplying the current fair market value of the facility by the federal share of the facility; or</p><p class="depth0"><em>(3)</em> The grantee shall transfer the title to either the United States or to an eligible non-federal party approved by the Director. The grantee shall be entitled to be paid an amount computed by multiplying the current fair market value of the facility by the nonfederal share of the facility.</p><p class="depth0"><em>(b)</em> The grantee or transferor of a facility which is sold or transferred, or the owner of a facility the use of which has changed, as described in paragraph (a) of this section, shall report that action in writing to the Director not later than 10 days from the date on which the sale, transfer, or change occurs, in the form and manner as the Director may prescribe.</p><p class="depth0"><em>(c)</em> In lieu of disposition of a facility pursuant to the provisions of paragraph (a) of this section, the Director may, for good cause, supported by assurances provided by the grantee or transferee, approve one of the following alternatives:</p><p class="depth0"><em>(1)</em> Transfer of the remaining usage obligation to facilities of substantially comparable or greater value or utility, to carry out the biomedical research or training purpose for which the grant was awarded. In this event, the remaining usage obligation shall be released from the original facility constructed with grant funds and transferred to the new facility, and the grantee shall remain subject to all other requirements imposed under this part with respect to the new facility; or</p><p class="depth0"><em>(2)</em> Use the facility for as long as needed, in order of priority, for one of the following purposes:</p><p class="depth0"><em>(i)</em> For other health related activities consistent with the purposes of one or more of the activities of the awarding institute as authorized under title IV or other provisions of the Act;</p><p class="depth0"><em>(ii)</em> To provide training and instruction in the health fields for health professionals or health related information programs for the public; or</p><p class="depth0"><em>(iii)</em> Other health related purposes consistent with one or more of the purposes authorized under the Act.</p><p class="depth0"><em>(d)</em> The right of recovery of the United States set forth in paragraph (a) of this section shall not, prior to judgment, constitute a lien on any facility supported in whole or in part by a federal grant, including a construction grant under this part.</p><p class="depth0"><em>(e)</em> Any amount required to be paid to the United States under this section will be paid to the awarding institute for disposition as required by law.
(Approved by the Office of Management and Budget under Control Number 0925-0424; expires November 30, 2001)



Sec.  52b.10  What are the terms and conditions of awards?</p><p class="depth0">In addition to any other requirement imposed by law or determined by the Director to be reasonably necessary to fulfill the purposes of the grant, each construction grant shall be subject to the terms and conditions and the grantee assurances required by this section, supported by such documentation as the Director may reasonably require. The Director may, by general policy or for good cause shown by an applicant, approve exceptions to these terms and conditions or assurances where the Director finds that the exceptions are consistent with the applicable provisions of the Act and the purposes of the particular program:</p><p class="depth0"><em>(a)</em> Title. The applicant must have a fee simple or other estate or interest in the site, including necessary easements and rights-of-way, sufficient to assure for the estimated useful life of the facility, as determined by the Director, undisturbed use and possession for the purpose of the construction and operation of the facility.</p><p class="depth0"><em>(b)</em> Plans and specifications. Approval by the Director of the final working drawings, specifications, and cost estimates must be obtained before the project is advertised or placed on the market for bidding. The approval must include a determination by the Director that the final plans and specifications conform to the minimum standards of construction and equipment as set forth in Sec.  52b.12.</p><p class="depth0"><em>(c)</em> Relocation assistance. An applicant with an approved project which involves the displacement of persons or businesses shall comply with the provisions of the Uniform Relocation Assistance and Real Property Acquisition Policies Act of 1970, as amended (42 U.S.C. 4601 et seq.) and the applicable regulations issued under that Act (45 CFR part 15; 49 CFR part 24).</p><p class="depth0"><em>(d)</em> Approval of changes in estimated cost. Unless approved by the Director, the applicant shall not enter into any construction contracts for the project or a part of the project, the cost of which exceeds the estimated cost approved in the terms of an award for that portion of the work covered by the plans and specifications. Exceptions shall be requested in the form and manner as the Director may prescribe.</p><p class="depth0"><em>(e)</em> Completion responsibility. The applicant must construct the project, or cause it to be constructed, to final completion in accordance with the grant application, the terms and conditions of the award, and the approved plans and specifications.</p><p class="depth0"><em>(f)</em> Construction schedule inspection. Prior to the start of construction, the grantee shall submit an approved copy of the construction schedule (critical path method) to the Director in the form and manner as the Director may prescribe.</p><p class="depth0"><em>(g)</em> Construction management. The applicant must provide and maintain competent and adequate construction management services for inspection at the construction site to ensure that the completed work conforms with the approved plans and specifications. Construction management services shall include daily construction logs and monthly status reports which shall be maintained at the job site and shall be submitted to the Director at the times and in the form and manner as the Director may prescribe.</p><p class="depth0"><em>(h)</em> Nonfederal share. Sufficient funds must be available to meet the nonfederal share of the costs of constructing the facility.</p><p class="depth0"><em>(i)</em> Funds for operation. Sufficient funds must be available when construction is completed for effective use of the facility for the purposes for which it is being constructed.</p><p class="depth0"><em>(j)</em> Inspection. The Director and the Director's representatives shall have access at all reasonable times to all work areas and documents during any stage of construction and the contractor shall provide proper facilities for this access and inspection.</p><p class="depth0"><em>(k)</em> Accessibility to handicapped persons. The facility must be designed to comply with the Uniform Federal Accessibility Standards (41 CFR part 101-19, subpart 101-19.6, Appendix A), as modified by other standards prescribed by the Director or the Administrator of General Services. The applicant shall conduct inspections to ensure compliance with these specifications by the contractor.</p><p class="depth0"><em>(l)</em> Notice of Federal Interest. The grantee shall record a Notice of Federal Interest in the appropriate official land records of the jurisdiction in which the property is located.</p><p class="depth0"><em>(m)</em> Title insurance. The grantee shall purchase a title insurance policy unless a legal opinion has been provided which certifies that the grantee institution has fee simple title to the site free and clear of all liens, easements, rights-of-way, and any other adverse interests which would encumber the project. The Director may waive this requirement upon a request from the grantee adequately documenting self-insurance against the risks involved and containing such other information as the Director may prescribe.</p><p class="depth0"><em>(n)</em> Physical destruction insurance. At the time construction is completed or at the time of beneficial occupancy, whichever comes first, the grantee shall purchase an insurance policy which insures the facility for the full appraised value of the property using state certified appraisers. The insurance policy must protect the property from total and partial physical destruction. The insurance policy must be maintained throughout the period of federal interest. The Director may waive this requirement upon a written request from the grantee adequately documenting self-insurance against the risks involved and containing such other information as the Director may prescribe.
(Approved by the Office of Management and Budget under Control Number 0925-0424; expires November 30, 2001)


Sec.  52b.11  What are the requirements for acquisition and modernization of existing facilities?</p><p class="depth0">Grant awards for the acquisition and modernization of existing facilities are permitted if authorized by the statutes authorizing the construction grant program and shall be subject to the requirements of this section.</p><p class="depth0"><em>(a)</em> Minimum standards of construction and equipment. A determination by the Director that the facility conforms (or upon completion of any necessary construction will conform) to the minimum standards of construction and equipment as set forth in Sec.  52b.12 shall be obtained before entering into a final or unconditional contract for the acquisition and/or modernization of facilities. Where the Director finds that exceptions to or modifications of these minimum standards would be consistent with the purposes of the applicable section of the Act under which the acquisition or modernization is supported, the Director may authorize the exceptions or modifications.</p><p class="depth0"><em>(b)</em> Estimated cost of acquisition and remodeling: suitability of facility. Each application for a project involving the acquisition of existing facilities shall include in the detailed estimates of the costs of the project, the cost of acquiring the facilities, and any cost of remodeling, renovating or altering the facilities to serve the purposes for which they are acquired. The application shall demonstrate to the satisfaction of the Director that the architectural, mechanical, electrical, plumbing, structural, and other pertinent features of the facility, as modified by any proposed expansion, remodeling, renovation, or alteration, will be suitable for the purposes of the applicable sections of the Act.</p><p class="depth0"><em>(c)</em> Bona fide sale. Grant awards for the acquisition of existing facilities shall be subject to the condition that the acquisition constitutes a bona fide sale involving an actual cost to the applicant and will result in additional or improved facilities for purposes of the applicable provisions of the Act.</p><p class="depth0"><em>(d)</em> Facility previously funded by a federal grant. No grant for the acquisition or modernization of a facility which has previously been funded in whole or in part by a federal grant for construction, acquisition, or equipment shall serve either to reduce or restrict the liability of the applicant or any other transferor or transferee from any obligation of accountability imposed by the Federal Government by reason of the prior grant.
(Approved by the Office of Management and Budget under Control Number 0925-0424; expires November 30, 2001)


Sec.  52b.12  What are the minimum requirements of construction and equipment?</p><p class="depth0"><em>(a)</em> General. In addition to being subject to other laws, regulations, executive orders, and policies referred to in

Sec.  52b.14, the standards set forth in this section have been determined by the Director to constitute minimum requirements of construction and equipment, including the expansion, remodeling, renovation, or alteration of existing buildings, and these standards, as may be amended, or any revisions or successors of these standards, shall apply to all projects for which federal assistance is requested under this part. The publications referenced in this section are hereby incorporated by reference and made a part of the regulations in this part.</p><p class="depth0"><em>(b)</em> Incorporation by reference. The Director of the Federal Register approves the incorporations by reference in paragraph (c) of this section in accordance with 5 U.S.C. 552(a)(1) and 1 CFR part 51. Copies may also be obtained from the organizations at the addresses listed in paragraph (c) of this section. Copies may be inspected at the National Cancer Institute, Executive Plaza North, Room 539, 6130 Executive Boulevard, Rockville, MD 20852 (telephone 301-496-8534; not a toll-free number); the National Center for Research Services, Building 31, Room 3B11, 9000 Rockville Pike, Bethesda, MD 20892 (telephone 301-496-5793); not a toll-free number); and at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html. The Director may for good cause shown, approve plans and specifications which contain deviations from the requirements prescribed in paragraph (c) of this section, if the Director is satisfied that the purposes of the requirements have been fulfilled. In addition to these requirements, each project shall meet the requirements of the applicable state and local codes and ordinances relating to construction.</p><p class="depth0"><em>(c)</em> Design and construction standards. The facility shall comply with the following mandatory design and construction standards:</p><p class="depth0"><em>(1)</em> ``Guidelines for Design and Construction of Hospital and Health Care Facilities'' (1996-97). American Institute of Architects Academy of Architecture for Health (AIA); available from AIA Rizzoli Catalogue Sales, 117 Post Street, San Francisco, CA 94108 (telephone 1-800-522-6657, fax 415-984-0024).</p><p class="depth0"><em>(2)</em> 1995 ASHRAE Handbook: Heating, Ventilating, and Air Conditioning Applications (1995), Chapter 13, ``Laboratory Systems.'' American Society of Heating, Refrigerating and Air Conditioning Engineers, Inc., 1791 Tullie Circle, NE, Atlanta, GA 30329 (telephone 404-636-8400).</p><p class="depth0"><em>(3)</em> ICBO ``Uniform Building Code,'' Volumes 1-3 (1997). International Conference of Building Officials (ICBO), 5360 South Workman Mill Road, Whittier, CA 90601-2298 (telephone 562-699-0541 or 800-284-4406).</p><p class="depth0"><em>(4)</em> BOCA National Building Code (1996) 1998 Supplement, Building Officials and Code Administrators International, Inc. (BOCA), 4051 West Fossmoor Road, Country Club Hills, IL 60478-5795 (telephone 708-799-4981; fax 708-799-4981).</p><p class="depth0"><em>(5)</em> ``Recommended Lateral Force Requirements and Commentary'' (1996). Structural Engineers Association of California; available from International Conference of Building Officials, 5360 South Workman Mill Road, Whittier, CA 90601-2298 (telephone 562-699-0541).</p><p class="depth0"><em>(6)</em> ``Prudent Practices in the Laboratory: Handling and Disposal of Chemicals'' (1995). National Research Council; available from National Academy Press, 8700 Spectrum Drive, Landover, MD 20785 (telephone 1-800-624-6242).</p><p class="depth0"><em>(7)</em> The following material is available for purchase from the National Fire Protection Association (NFPA), 11 Tracy Drive, Avon, MA 02322-9908 (telephone 617-770-3000 or 1-800-735-0100):</p><p class="depth0"><em>(i)</em> NFPA 45, ``Standard on Protection for Laboratories Using Chemicals'' (1996).</p><p class="depth0"><em>(ii)</em> NFPA 70, ``National Electric Code'' (1996).</p><p class="depth0"><em>(iii)</em> NFPA 99, Chapter 4, ``Gas and Vacuum Systems'' (1996).</p><p class="depth0"><em>(iv)</em> NFPA 101, ``Life Safety Code'' (1997).</p><p class="depth0"><em>(v)</em> NFPA ``Health Care Facilities Handbook'' (1996).</p><p class="depth0"><em>(8)</em> NSF Standard No. 49 for Class II (Laminar Flow) Biohazard Cabinetry (1992). National Sanitation Foundation

(NSF), 3475 Plymouth Road, Box 1468, Ann Arbor, MI 48106 (telephone 734-769-9010).</p><p class="depth0"><em>(9)</em> ACGIH ``Industrial Ventilation: A Manual of Recommended Practice'' (1998). American Conference of Governmental Industrial Hygienists (ACGIH), 1330 Kemper Meadow Drive, Cincinnati, OH 45240-1634 (telephone 513-742-2020).</p><p class="depth0"><em>(10)</em> AIHA ``Laboratory Ventilation Workbook'' (1994). American Industrial Hygiene Association (AIHA), 2700 Prosperity Avenue, Suite 250, Fairfax, VA 22031 (telephone 703-849-8888).</p><p class="depth0"><em>(11)</em> The following material is available for purchase from the Southern Building Code Congress (SBCC), 900 Montclair Road, Birmingham, AL 35213-1206 (telephone 205-591-1853; fax 202-591-0075:</p><p class="depth0"><em>(i)</em> SBCC ``International Standard Plumbing Code'' (1997).</p><p class="depth0"><em>(ii)</em> SBCC ``Standard Building Code'' (1997).
[64 FR 63722, Nov. 22, 1999, as amended at 69 FR 18803, Apr. 9, 2004]


Sec.  52b.13  Additional conditions.</p><p class="depth0">The Director may with respect to any grant award impose additional conditions consistent with the regulations of this part prior to or at the time of any award when in the Director's judgment the conditions are necessary to assure or protect advancement of the approved project, the purposes of the applicable provisions of the Act, or the conservation of grant funds.


Sec.  52b.14  Other federal laws, regulations, executive orders, and policies that apply.</p><p class="depth0">Other federal laws, regulations, executive orders, and policies apply to grants under this part. These include, but are not necessarily limited to:</p><p class="depth0"><em>(a)</em> Laws.</p><p class="depth0">An Act to Provide for the Preservation of Historical and Archeological Data (and other purposes), as amended (16 U.S.C. 469 et seq.).
Architectural Barriers Act of 1968, as amended (42 U.S.C. 4151 et seq.).Earthquake Hazards Reduction Act of 1977, as amended (42 U.S.C. 7701 et seq.).Flood Disaster Protection Act of 1973, section 202, as amended (42 U.S.C. 4106).National Historic Preservation Act, section 106, as amended (16 U.S.C. 470f).Safe Drinking Water Act, as amended (42 U.S.C. 300f et seq.).</p><p class="depth0"><em>(b)</em> Regulations.
9 CFR part 3--Standards (Animal Welfare).29 CFR 1910.1450--Occupational exposure to hazardous chemicals in laboratories.36 CFR part 1190--Minimum guidelines and requirements for accessible design.41 CFR part 101-19, subpart 101-19.6--Accommodations for the physically handicapped.41 CFR part 101-19, subpart 101-19.6, Appendix A--Uniform Federal accessibility standards.42 CFR part 50, subpart A--Responsibility of PHS awardee and applicant institutions for dealing with and reporting possible misconduct in science.42 CFR part 50, subpart D--Public Health Service grant appeals procedure.45 CFR part 15--Uniform relocation assistance and real property acquisition for Federal and federally assisted programs.45 CFR part 16--Procedures of the Departmental Grant Appeals Board.45 CFR part 46--Protection of human subjects.45 CFR part 74--Uniform administrative requirements for awards and subawards to institutions of higher education, hospitals, other nonprofit organizations, and commercial organizations; and certain grants and agreements with states, local governments and Indian tribal governments.45 CFR part 76--Governmentwide debarment and suspension (nonprocurement) and governmentwide requirements for drug-free workplace (grants).45 CFR part 80--Nondiscrimination under programs receiving Federal assistance through the Department of Health and Human Services--effectuation of title VI of the Civil Rights Act of 1964.45 CFR part 81--Practice and procedure for hearings under part 80 of this chapter.45 CFR part 84--Nondiscrimination on the basis of handicap in programs and activities receiving Federal financial assistance.45 CFR part 86--Nondiscrimination on the basis of sex in education programs and activities receiving or benefitting from Federal financial assistance.45 CFR part 91--Nondiscrimination on the basis of age in HHS programs or activities receiving Federal financial assistance.45 CFR part 92--Uniform administrative requirements for grants and cooperative agreements to State and local governments.45 CFR part 93--New restrictions on lobbying.49 CFR part 24--Uniform relocation assistance and real property acquisition for Federal and federally assisted programs.</p><p class="depth0"><em>(c)</em> Executive orders.
Executive Order 11988, Floodplain Management (May 24, 1977)(3 CFR, 1977 Comp., p. 117).Executive Order 11990, Protection of Wetlands (May 24, 1977)(3 CFR, 1977 Comp., p. 121).Executive Order 12699, Seismic Safety of Federal and Federally Assisted or Regulated New Building Construction (January 5, 1990)(3 CFR, 1990 Comp., p. 269).</p><p class="depth0"><em>(d)</em> Policies. (1) Design Policy and Guidelines (1996). Division of Engineering Services, National Institutes of Health (Note: To obtain copies of the policy, interested persons should contact the Division of Engineering Services, 9000 Rockville Pike, Building 13, Room 2E43, Bethesda, MD 20892 (telephone 301-496-6186; not a toll-free number) or visit the following site on the World Wide Web (http://des.od.nih/gov/nihpol.html).).</p><p class="depth0"><em>(2)</em> NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research (1994) (Note: To obtain copies of the policy, interested persons should contact the Office of Research on Women's Health, NIH, Room 201, Building 1, MSC 0161, Bethesda, MD 20892-0161 (telephone 301-402-1770; not a toll-free number).).</p><p class="depth0"><em>(3)</em> NIH Guidelines for Research Involving Recombinant DNA Molecules (1994) (Note: To obtain copies of the policy, interested persons should contact the Office of Recombinant DNA Activities, NIH, 6000 Executive Boulevard, Suite 323, MSC 7010, Bethesda, MD 20892-7010 (telephone 301-496-9838; not a toll-free number).).</p><p class="depth0"><em>(4)</em> ``NIH Grants Policy Statement.'' NIH Pub. No. 99-80 (Oct. 1998) (Note: To obtain copies of the policy, interested persons should contact the Extramural Outreach and Information Resources Office (EOIRO), Office of Extramural Research, NIH, 6701 Rockledge Drive, Room 6208, MSC 7910, Bethesda, MD 20892-7910 (telephone 301-435-0714; not a toll-free number). Information may also be obtained by contacting the EOIRO via its e-mail address (asknih@odrockml.od.nih.gov) and by browsing the NIH Home Page site on the World Wide Web (http://www.nih.gov).).</p><p class="depth0"><em>(5)</em> ``Guide for the Care and Use of Laboratory Animals (1996). Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council (Note: To obtain copies of the policy, interested persons should contact the Office for Protection from Research Risks, NIH, 6100 Executive Boulevard, Suite 3B01, MSC 7507, Rockville, MD 20852-7507 (telephone 301-496-7005; not a toll-free number).).</p><p class="depth0"><em>(6)</em> ``Public Health Service Policy on Humane Care and Use of Laboratory Animals.'' (Rev. Sept. 1986). Office for Protection from Research Risks, NIH (Note: To obtain copies of the policy, interested persons should contact the Office for Protection from Research Risks, NIH, 6100 Executive Boulevard, Suite 3B01, MSC 7507, Rockville, MD 20852-7507 (telephone 301-496-7005; not a toll-free number).).</p><p class="depth0"><em>(7)</em> ``Biosafety in Microbiological and Biomedical Laboratories.'' DHHS Publication No. (CDC) 88-8395 (1993). Centers for Disease Control and Prevention (CDC) (Note: To obtain copies of the policy, interested persons should contact the Division of Safety, Occupational Safety and Health Branch, NIH, 13 South Drive, Room 3K04, MSC 5760, Bethesda, MD 20892-5760 (telephone 301-496-2960; not a toll-free number).).</p><p class="depth0"><em>(8)</em> ``NIH Guidelines for the Laboratory Use of Chemical Carcinogens,'' DHHS Publication No. (NIH) 81-2385 (May 1981) (Note: To obtain copies of the policy, interested persons should contact the Division of Safety, Occupational Safety and Health Branch, NIH, 13 South Drive, Room 3K04, MSC 5760, Bethesda, MD 20892-5760 (telephone 301-496-2960; not a toll-free number).).</p><p class="depth0"><em>(9)</em> ``NIH Policy and Guidelines on the Inclusion of Children as Participants in Research Involving Human Subjects (March 6, 1998).'' NIH Guide for Grants and Contracts (Note: To obtain copies of the policy, interested persons should contact the Office of Extramural Research, NIH, 6701 Rockledge Drive, Room 6208, MSC 7910, Bethesda, MD 20817-7910 (telephone 301-435-0714; not a toll-free number). Information may also be obtained by browsing the NIH Home Page site on the World Wide Web (http://www.nih.gov).).



PART 52c_MINORITY BIOMEDICAL RESEARCH SUPPORT PROGRAM--Table of Contents


Sec.52c.1 Applicability.52c.2 Definitions.52c.3 Eligibility.52c.4 Application.52c.5 Grant awards.52c.6 Expenditure of grant funds.52c.7 Other HHS regulations that apply.52c.8 Additional conditions.</p><p class="depth0">Authority: 42 U.S.C. 216, 241(a)(3).</p><p class="depth0">Source: 45 FR 12246, Feb. 25, 1980, unless otherwise noted.


Sec.  52c.1  Applicability.</p><p class="depth0">The regulations in this part apply to grants (under the Minority Biomedical Research Support Program) awarded in accordance with section 301(a)(3) of the Public Health Service (PHS) Act (42 U.S.C. 241(a)(3)) to increase the numbers of ethnic minority faculty, students, and investigators engaged in biomedical research, and to broaden the opportunities for participation in biomedical research of ethnic minority faculty, students, and investigators, by providing general support for biomedical research programs at eligible institutions.
[58 FR 61030, Nov. 19, 1993]


Sec.  52c.2  Definitions.</p><p class="depth0">As used in this part:</p><p class="depth0">Act means the Public Health Service Act, as amended (42 U.S.C. 201 et seq.).</p><p class="depth0">Ethnic minorities includes but is not limited to such groups as Black Americans, Hispanic Americans, Asian/Pacific Islanders, and American Indians/Native Alaskans (Native Americans).</p><p class="depth0">HHS means the Department of Health and Human Services.</p><p class="depth0">Nonprofit as applied to any institution means an institution which is a corporation or association no part of the net earnings of which inures or may lawfully inure to the benefit of any private shareholder or individual.</p><p class="depth0">Program director means a single individual, designated in the grant application, who is scientifically trained and has research experience and who is responsible for the overall execution of the program supported under this part at the grantee institution.</p><p class="depth0">Secretary means the Secretary of Health and Human Services and any other officer or employee of the Department of Health and Human Services to whom the authority involved has been delegated.
[58 FR 61030, Nov. 19, 1993]


Sec.  52c.3  Eligibility.</p><p class="depth0">To be eligible for a grant under this Program, an applicant must be:</p><p class="depth0"><em>(a)</em> One of the following:</p><p class="depth0"><em>(1)</em> A public or private nonprofit university, four year college, or other institution offering undergraduate, graduate, or health professional degrees, with a traditionally high (more than 50 percent) minority student enrollment;</p><p class="depth0"><em>(2)</em> A public or private nonprofit two year college with a traditionally high (more than 50 percent) minority student enrollment;</p><p class="depth0"><em>(3)</em> A public or private nonprofit university, four year college, or other institution offering undergraduate, graduate, or health professional degrees, with a student enrollment a significant proportion (but not necessarily more than 50 percent) of which is derived from ethnic minorities, provided the Secretary determines that said institution has a demonstrated commitment to the special encouragement of and assistance to ethnic minority faculty, students, and investigators; or</p><p class="depth0"><em>(4)</em> An Indian tribe which has a recognized governing body which performs substantial governmental functions, or an Alaska Regional Corporation as defined in the Alaska Native Claims Settlement Act (43 U.S.C. 1601 et seq.), and</p><p class="depth0"><em>(b)</em> Located in a State, the District of Columbia, Puerto Rico, the Virgin Islands, the Canal Zone, Guam, American Samoa, or the successor States of the Trust Territory of the Pacific Islands (the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau).
[45 FR 12246, Feb. 25, 1980; 45 FR 20096, Mar. 27, 1980; 58 FR 61030, Nov. 19, 1993]


Sec.  52c.4  Application.</p><p class="depth0">An institution interested in applying for a grant under this part must submit an application at the time and in the

form and manner that the Secretary may prescribe.
[58 FR 61030, Nov. 19, 1993]


Sec.  52c.5  Grant awards.</p><p class="depth0"><em>(a)</em> Within the limits of funds available, and upon such recommendation as may be required by law, the Secretary shall award grants to those applications with proposed biomedical research programs which will, in the Secretary's judgment, best promote the purposes of this part, taking into consideration among other pertinent factors:</p><p class="depth0"><em>(1)</em> The benefits that can be expected to accrue to the national effort in biomedical research and in increasing the pool of biomedical researchers;</p><p class="depth0"><em>(2)</em> The institution's capability, from a scientific and technical standpoint, to engage in biomedical research;</p><p class="depth0"><em>(3)</em> The benefits that can be expected to accrue to the institution and its students;</p><p class="depth0"><em>(4)</em> The administrative and managerial capability and competence of the applicant;</p><p class="depth0"><em>(5)</em> The availability of the facilities and resources (including where necessary collaborative arrangements with other institutions) to engage in biomedical research;</p><p class="depth0"><em>(6)</em> The applicant's relative need for funding; and</p><p class="depth0"><em>(7)</em> The overall significance of the proposal in terms of numbers of ethnic minority persons benefited thereby.</p><p class="depth0"><em>(b)</em> The notice of grant award specifies how long HHS intends to support the project without requiring the project to recompete for funds. This period, called the project period, will usually be for 1-5 years.</p><p class="depth0"><em>(c)</em> Generally the grant will initially be for one year and subsequent continuation awards will also be for one year at a time. A grantee must submit a separate application to have the support continued for each subsequent year. Decisions regarding continuation awards and the funding level of such awards will be made after consideration of such factors as the grantee's progress and management practices, and the availability of funds. In all cases, continuation awards require a determination by HHS that continued funding is in the best interest of the government.</p><p class="depth0"><em>(d)</em> Neither the approval of any application nor the award of any grant commits or obligates the United States in any way to make any additional, supplemental, continuation, or other award with respect to any approved application or portion of an approved application.
[45 FR 12246, Feb. 25, 1980; 45 FR 20096, Mar. 27, 1980; 58 FR 61030, Nov. 19, 1993]


Sec.  52c.6  Expenditure of grant funds.</p><p class="depth0"><em>(a)</em> Any funds granted pursuant to this part shall be expended solely for the purposes for which the funds were granted in accordance with the approved application and budget, the regulations of this part, the terms and conditions of the award, and the applicable cost principles prescribed by subpart Q of 45 CFR part 74.</p><p class="depth0"><em>(b)</em> The Secretary may permit unobligated grant funds remaining in the grant account at the close of a budget period to be carried forward for obligation during a subsequent budget period, provided a continuation award is made for that period and the Secretary's written approval is obtained. The amount of any subsequent award will take into consideration unobligated grant funds remaining in the grant account.
[45 FR 12246, Feb. 25, 1980; 45 FR 20096, Mar. 27, 1980; 45 FR 68392, Oct. 15, 1980]


Sec.  52c.7  Other HHS regulations that apply.</p><p class="depth0">Several other regulations and policies apply to grants under this part. These include, but are not necessarily limited to:
37 CFR part 401--Rights to inventions made by nonprofit organizations and small business firms under government grants, contracts, and cooperative agreements42 CFR part 50, subpart A--Responsibilities of PHS awardee and applicant institutions for dealing with and reporting possible misconduct in science42 CFR part 50, subpart D--Public Health Service grant appeals procedures45 CFR part 16--Procedures of the Departmental Grant Appeals Board45 CFR part 46--Protection of human subjects45 CFR part 74--Administration of grants

45 CFR part 75--Informal grant appeals procedures45 CFR part 76--Governmentwide debarment and suspension (nonprocurement) and governmentwide requirements for drug-free workplace (grants)45 CFR part 80--Nondiscrimination under programs receiving Federal assistance through the Department of Health and Human Services Effectuation of Title VI of the Civil Rights Act of 196445 CFR part 81--Practice and procedure for hearings under part 80 of this title45 CFR part 84--Nondiscrimination on the basis of handicap in programs and activities receiving Federal financial assistance45 CFR part 86--Nondiscrimination on the basis of sex in education programs and activities receiving or benefiting from Federal financial assistance45 CFR part 91--Nondiscrimination on the basis of age in HHS programs and activities receiving Federal financial assistance45 CFR part 92--Uniform administrative requirements for grants and cooperative agreements to State and local governments45 CFR part 93--New restrictions on lobbying51 FR 16958, or successor--NIH Guidelines for Research Involving Recombinant DNA Molecules``Public Health Service Policy on Humane Care and Use of Laboratory Animals,'' Office for Protection from Research Risks, NIH (Revised September 1986), or successor
[58 FR 61030, Nov. 19, 1993]


Sec.  52c.8  Additional conditions.</p><p class="depth0">The Secretary may with respect to any grant award impose additional conditions prior to or at the time of any award when in the Secretary's judgment those conditions are necessary to assure or protect advancement of the approved program, the interests of the public health, or the conservation of grant funds.


PART 52d_NATIONAL CANCER INSTITUTE CLINICAL CANCER EDUCATION PROGRAM--Table of Contents


Sec.52d.1 Applicability.52d.2 Definitions.52d.3 Eligibility.52d.4 Application.52d.5 Program requirements.52d.6 Grant awards.52d.7 Expenditure of grant funds.52d.8 Other HHS regulations that apply.52d.9 Additional conditions.</p><p class="depth0">Authority: Sec. 215, 58 Stat. 690, as amended, 63 Stat. 835 (42 U.S.C. 216); sec. 404(a)(4), 92 Stat. 3426 (42 U.S.C. 285).</p><p class="depth0">Source: 45 FR 12247, Feb. 25, 1980, unless otherwise noted.


Sec.  52d.1  Applicability.</p><p class="depth0">The regulations in this part apply to grants under the Clinical Cancer Education Program authorized by section 404(a)(4) of the Public Health Service Act, to encourage planning and development of multidisciplinary educational programs aimed at achieving optimal care of cancer patients and to enable students in the health professions to acquire basic knowledge of neoplastic disease and the preventive measures and diagnostic and therapeutic skills necessary to the provision of such care.


Sec.  52d.2  Definitions.</p><p class="depth0"><em>(a)</em> Act means the Public Health Service Act, as amended.</p><p class="depth0"><em>(b)</em> Director, NCI, means the Director of the National Cancer Institute and any other officer or employee of said Institute to whom the authority involved has been delegated.</p><p class="depth0"><em>(c)</em> [Reserved]</p><p class="depth0"><em>(d)</em> Board means the National Cancer Advisory Board established by section 407 of the Act (42 U.S.C. 286b).</p><p class="depth0"><em>(e)</em> Affiliated teaching hospital means a hospital which, although not owned by such school, has a written agreement with a school of medicine, osteopathy, dentistry, or public health eligible for assistance under this part, providing for effective control by the school of the teaching in the hospital.</p><p class="depth0"><em>(f)</em> Specialized cancer institute means an institution which has as its primary mission the diagnosis, prevention, or treatment of cancer.
[45 FR 12247, Feb. 25, 1980; 45 FR 20096, Mar. 27, 1980, as amended at 47 FR 53012, Nov. 24, 1982]


Sec.  52d.3  Eligibility.</p><p class="depth0">To be eligible for a grant under this part, an applicant must be:</p><p class="depth0"><em>(a)</em> A public or private school of medicine, osteopathy, dentistry, or public health, affiliated teaching hospital, or specialized cancer institute; and</p><p class="depth0"><em>(b)</em> Located in a State, the District of Columbia, Puerto Rico, the Virgin Islands, the Canal Zone, Guam, American Samoa, or the Trust Territory of the Pacific Islands.
[45 FR 12247, Feb. 25, 1980, as amended at 47 FR 53012, Nov. 24, 1982]


Sec.  52d.4  Application.</p><p class="depth0"><em>(a)</em> Application for a grant under this subpart shall be made on an authorized form. \1\ Applicants shall submit completed forms, on or before the dates the Director, NCI, may prescribe.---------------------------------------------------------------------------</p><p class="depth0">\1\ Applications and instructions are available from the Division of Cancer Research Resources and Centers, Education Branch, Westwood Building, 5333 Westbard Avenue, Bethesda, MD 20205.---------------------------------------------------------------------------</p><p class="depth0"><em>(b)</em> [Reserved]</p><p class="depth0"><em>(c)</em> In addition to any other pertinent information that the Director, NCI, may require, each application shall set forth in detail:</p><p class="depth0"><em>(1)</em> A program plan defining the objectives of the proposed program and the means by which these objectives would be achieved, including descriptions of:</p><p class="depth0"><em>(i)</em> The general educational level (e.g., pre-doctoral, post-doctoral) of the students to be involved in the program;</p><p class="depth0"><em>(ii)</em> The proposed course of study and its relation to the diagnosis, prevention, control, and treatment of cancer;</p><p class="depth0"><em>(iii)</em> The clinical experiences to be provided to the students;</p><p class="depth0"><em>(iv)</em> Multidisciplinary aspects of the program;</p><p class="depth0"><em>(v)</em> The particular schools or branches within the institution which would have responsibility for individual aspects of the program; and</p><p class="depth0"><em>(vi)</em> The teaching mechanisms to be employed, including specific discussion of those techniques which would be innovative.</p><p class="depth0"><em>(2)</em> The availability of personnel, facilities, and resources needed to carry out the program;</p><p class="depth0"><em>(3)</em> The names, qualifications, and proposed duties of the program director and any staff members who would be responsible for the program, including a description of those duties which would actually be carried out by the program director and those which would be shared with or assigned to others;</p><p class="depth0"><em>(4)</em> The names and qualifications of proposed members of a cancer education committee which would be established by the applicant to advise it on the planning, organization, operation and evaluation of the program and the specific duties which would be assigned to said committee;</p><p class="depth0"><em>(5)</em> Insofar as necessary, cooperative arrangements with other schools, hospitals, and institutions which would participate in the program;</p><p class="depth0"><em>(6)</em> The proposed project period, a detailed budget for the first budget period including a list of other anticipated sources of support and anticipated total needs for each of the succeeding budget periods of the requested project period, and a justification for the amount of grant funds requested;</p><p class="depth0"><em>(7)</em> Proposed methods for monitoring and evaluating the program; and</p><p class="depth0"><em>(8)</em> A description of how the education and training effort will be sustained upon expiration of the award.
[45 FR 12247, Feb. 25, 1980, as amended at 47 FR 53012, Nov. 24, 1982]


Sec.  52d.5  Program requirements.</p><p class="depth0"><em>(a)</em> If the program is to be offered at the graduate level, it must be multidisciplinary in scope involving at least two or more clinical or preclinical sciences relating to cancer;</p><p class="depth0"><em>(b)</em> The cancer education committee provided for in the approved application must meet at least four times per year, and must be chaired by the program director.


Sec.  52d.6  Grant awards.</p><p class="depth0"><em>(a)</em> Within the limits of funds available, after consultation with the Board, the Director, NCI, may award grants to applicants with proposed programs which in the NCI Director's judgment best promote the purposes of this part, taking into consideration among other pertinent factors:</p><p class="depth0"><em>(1)</em> The relevance of the proposed program to the objectives of this part;</p><p class="depth0"><em>(2)</em> The extent to which the program would involve innovative teaching techniques;</p><p class="depth0"><em>(3)</em> The availability of adequate staff, facilities, and resources (including

where necessary cooperative arrangements with other institutions or hospitals) to carry out the program;</p><p class="depth0"><em>(4)</em> The qualifications and experience of the program director;</p><p class="depth0"><em>(5)</em> The authority of the program director to ensure that the program is planned with multidisciplinary input and that multidisciplinary aspects of the program are carried out;</p><p class="depth0"><em>(6)</em> The extent to which the cancer education committee is broadly representative of the disciplines concerned with cancer care and teaching and is allowed to participate in the planning, organization, operation, and evaluation of the program;</p><p class="depth0"><em>(7)</em> If the program is to be offered at the pre-doctoral level, the extent to which its objectives are designed to aid students:</p><p class="depth0"><em>(i)</em> To acquire a basic understanding of fundamental principles of cancer biology, epidemiology, detection, diagnosis, prevention, treatment and control;</p><p class="depth0"><em>(ii)</em> To interest students in learning more about cancer; and</p><p class="depth0"><em>(iii)</em> To develop an appreciation of the need for a comprehensive multidisciplinary approach to the care of cancer patients;</p><p class="depth0"><em>(8)</em> The administrative and managerial capability of the applicant;</p><p class="depth0"><em>(9)</em> The reasonableness of the proposed budget in relation to the proposed program;</p><p class="depth0"><em>(10)</em> The adequacy of the methods for monitoring and evaluating the program on a continuing basis; and</p><p class="depth0"><em>(11)</em> The degree to which the application adequately provides for the requirements set forth in Sec.  52d.5.</p><p class="depth0"><em>(b)</em> The notice of grant award specifies how long HHS intends to support the program without requiring the program to recompete for funds. This period, called the project period, will usually be for 1-5 years.</p><p class="depth0"><em>(c)</em> Generally, the grant will initially be for one year and subsequent continuation awards will also be for one year at a time. A grantee must submit a separate application to have the support continued for each subsequent year. Decisions regarding continuation awards and the funding level of such awards will be made after consideration of such factors as the grantee's progress and management practices, and the availability of funds. In all cases, continuation awards require a determination by HHS that continued funding is in the best interest of the government.</p><p class="depth0"><em>(d)</em> Neither the approval of any application nor the award of any grant commits or obligates the United States in any way to make any additional, supplemental, continuation, or other award with respect to any approved application or portion of an approved application.


Sec.  52d.7  Expenditure of grant funds.</p><p class="depth0"><em>(a)</em> Any funds granted pursuant to this part shall be expended solely for the purposes for which the funds were granted in accordance with the approved application and budget, the regulations of this part, the terms and conditions of the awards, and the applicable cost principles prescribed by subpart Q of 45 CFR part 74, except that grant funds may not be used for costs incurred in connection with activities which, prior to the grant, were part of the grantee's standard curriculum.</p><p class="depth0"><em>(b)</em> The Director, NCI, may permit unobligated grant funds remaining in the grant account at the close of a budget period to be carried forward for obligation during a subsequent budget period, provided a continuation award is made for that period and the NCI Director's written approval is obtained. The amount of any subsequent award will take into consideration unobligated grant funds remaining in the grant account.


Sec.  52d.8  Other HHS regulations that apply.</p><p class="depth0">Several other regulations apply to grants under this subpart. These include, but are not limited to:
42 CFR part 50, subpart D--Public Health Service grant appeals procedure45 CFR part 16--Procedures of the Departmental Grant Appeals Board45 CFR part 74--Administration of grants45 CFR part 75--Informal grant appeals procedures45 CFR part 80--Nondiscrimination under programs receiving Federal assistance through the Department of Health and Human Services effectuation of title VI of the Civil Rights Act of 1964

45 CFR part 81--Practice and procedure for hearings under part 80 of this title45 CFR part 84--Nondiscrimination on the basis of handicap in programs and activities receiving or benefiting from Federal financial assistance45 CFR part 86--Nondiscrimination on the basis of sex in education programs and activities receiving or benefiting from Federal financial assistance45 CFR part 91--Nondiscrimination on the basis of age in HHS programs or activities receiving Federal financial assistance
[49 FR 38111, Sept. 27, 1984]


Sec.  52d.9  Additional conditions.</p><p class="depth0">The Director, NCI, may with respect to any grant award impose additional conditions prior to or at the time of any award when in the NCI Director's judgment those conditions are necessary to assure or protect advancement of the approved program, the interests of the public health, or the conservation of grant funds.


PART 52e_NATIONAL HEART, LUNG, AND BLOOD INSTITUTE GRANTS FOR PREVENTION AND CONTROL PROJECTS--Table of Contents


Sec.52e.1 To what programs do these regulations apply?52e.2 Definitions.52e.3 Who is eligible to apply?52e.4 How to apply.52e.5 What are the project requirements?52e.6 How will NIH evaluate applications?52e.7 What are the terms and conditions of awards?52e.8 Other HHS regulations and policies that apply.52e.9 Additional conditions.</p><p class="depth0">Authority: 42 U.S.C. 216, 285b-1.</p><p class="depth0">Source: 45 FR 12249, Feb. 25, 1980, unless otherwise noted.


Sec.  52e.1  To what programs do these regulations apply?</p><p class="depth0"><em>(a)</em> This part applies to grants under section 419 of the Act (42 U.S.C. 285b-1) for projects to:</p><p class="depth0"><em>(1)</em> Demonstrate and evaluate the effectiveness of new techniques or procedures for the prevention and control of heart, blood vessel, lung, and blood diseases, with special consideration given to the prevention and control of these diseases in children, and in populations that are at increased risk with respect to such diseases;</p><p class="depth0"><em>(2)</em> Develop and evaluate methods of educating health practitioners concerning the prevention and control of these diseases; and</p><p class="depth0"><em>(3)</em> Develop and evaluate methods of educating the public concerning the prevention and control of these diseases.</p><p class="depth0"><em>(b)</em> For purposes of this part, prevention and control projects shall include community-based and population-based programs carried out in cooperation with other Federal agencies, with public health agencies of State or local governments, with nonprofit private entities that are community-based health agencies, or with other appropriate public or nonprofit private entities.
[45 FR 12249, Feb. 25, 1980; 45 FR 20097, Mar. 27, 1980, as amended at 58 FR 54298, Oct. 21, 1993; 59 FR 59372, Nov. 17, 1994]


Sec.  52e.2  Definitions.</p><p class="depth0">As used in this part:</p><p class="depth0">Act means the Public Health Service Act, as amended (42 U.S.C. 201 et seq.).</p><p class="depth0">Council means the National Heart, Lung, and Blood Advisory Council, established under section 406 of the Act (42 U.S.C. 284a).</p><p class="depth0">Director means the Director of the National Heart, Lung, and Blood Institute and any official to whom the authority involved may be delegated.</p><p class="depth0">Emergency medical services means the services utilized in responding to the perceived individual need for immediate medical care in order to prevent loss of life or aggravation of physiological or psychological illness or injury.</p><p class="depth0">HHS means the Department of Health and Human Services.</p><p class="depth0">National program means the National Heart, Blood Vessel, Lung, and Blood Diseases and Blood Resources Program referred to in section 421 of the Act (42 U.S.C. 285b-3).</p><p class="depth0">Nonprofit as applied to any agency or institution means an agency or institution which is a corporation or an association, no part of the net earnings of which inures or may lawfully inure to the benefit of any private shareholder or individual.</p><p class="depth0">PHS means the Public Health Service.
[58 FR 54298, Oct. 21, 1993]


Sec.  52e.3  Who is eligible to apply?</p><p class="depth0">To be eligible for a grant under this part, an applicant must be a public or nonprofit private agency or institution.
[45 FR 12249, Feb. 25, 1980, as amended at 58 FR 54298, Oct. 21, 1993]


Sec.  52e.4  How to apply.</p><p class="depth0"><em>(a)</em> Application for a grant under this subpart shall be made on an authorized form. \2\ Applicants shall submit completed forms on or before the dates the Director may prescribe.---------------------------------------------------------------------------</p><p class="depth0">\2\ Applications and instructions are available from the Division of Extramural Affairs, National Heart, Lung, and Blood Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20205.---------------------------------------------------------------------------</p><p class="depth0"><em>(b)</em> Each private institution which does not already have on file with the National Institutes of Health evidence of nonprofit status, must submit with its application acceptable proof of such status.</p><p class="depth0"><em>(c)</em> In addition to any other pertinent information that the Director may require each application shall set forth in detail:</p><p class="depth0"><em>(1)</em> The nature and purpose of the proposed project and the methods to be employed in carrying it out;</p><p class="depth0"><em>(2)</em> The relevance of the proposed project to the National Program;</p><p class="depth0"><em>(3)</em> The defined population to participate in the proposed project and the rationale for its selection;</p><p class="depth0"><em>(4)</em> With respect to applications relating to projects covered by Sec.  52e.1(a)(1), prior research findings on which the proposed project is based;</p><p class="depth0"><em>(5)</em> The personnel, facilities, and other resources, including community resources, available to carry out the proposed project;</p><p class="depth0"><em>(6)</em> Current activities of the applicant involving prevention or control of heart, blood vessel, lung, and blood diseases, the sources of funding for such activities, and the anticipated relationship of these activities to the proposed project;</p><p class="depth0"><em>(7)</em> The names and qualifications of the project director and key staff members who would be responsible for conducting the proposed project;</p><p class="depth0"><em>(8)</em> Proposed methods for monitoring and evaluating the project; and</p><p class="depth0"><em>(9)</em> The proposed project period; a detailed budget for the first budget period, including a list of other anticipated sources of support and anticipated total needs for each of the succeeding budget periods of the requested project period; and a justification for the amount of grant funds requested.
[45 FR 12249, Feb. 25, 1980, as amended at 58 FR 54298, Oct. 21, 1993]


Sec.  52e.5  What are the project requirements?</p><p class="depth0"><em>(a)</em> An approvable application must demonstrate to the satisfaction of the Director that:</p><p class="depth0"><em>(1)</em> With respect to applications relating to projects covered by Sec.  52e.1(a)(1), the techniques or procedures to be demonstrated and evaluated have been found safe and effective in the research setting and, based upon research findings, appear to have the potential for general applicability to the prevention, diagnosis, or treatment of heart, blood vessel, lung, or blood diseases;</p><p class="depth0"><em>(2)</em> With respect to applications relating to projects covered by Sec.  52e.1(a)(2) and Sec.  52e.1(a)(3), the project will include development and evaluation of one or more methods for educating health practitioners or the public concerning advances in the prevention, diagnosis, or treatment of such diseases; and</p><p class="depth0"><em>(3)</em> The nature of the project is such that its completion may be anticipated within the project period, or such other period as may be specified in the application.</p><p class="depth0"><em>(b)</em> The project must, in the judgment of the Director, be necessary for cooperation by the National Heart, Lung, and Blood Institute with one or more other Federal Health agencies, State, local or regional public health agencies, or nonprofit private health agencies in the diagnosis, prevention, or treatment of heart, blood vessel, lung or blood diseases.
[45 FR 12249, Feb. 25, 1980, as amended at 58 FR 54298, 54299, Oct. 21, 1993]



Sec.  52e.6  How will NIH evaluate applications?</p><p class="depth0"><em>(a)</em> Within the limits of funds available, after consultation with the Council, the Director may award grants to applicants with proposed projects which in the Director's judgment will best promote the purposes of section 419 of the Act, taking into consideration among other pertinent factors:</p><p class="depth0"><em>(1)</em> The scientific and technical merit of the proposed project;</p><p class="depth0"><em>(2)</em> The significance of the project in relation to the goals of the National Program;</p><p class="depth0"><em>(3)</em> Whether the project appropriately emphasizes the prevention, diagnosis, or treatment of heart, blood vessel, lung, or blood diseases of children;</p><p class="depth0"><em>(4)</em> The qualifications and experience of the project director and other key personnel;</p><p class="depth0"><em>(5)</em> The administrative and managerial capability and fiscal responsibility of the applicant;</p><p class="depth0"><em>(6)</em> The reasonableness of the proposed budget in relation to the proposed project;</p><p class="depth0"><em>(7)</em> The adequacy of the methods proposed for monitoring and evaluating the proposed project; and</p><p class="depth0"><em>(8)</em> The degree to which the application adequately provides for the requirements set forth in Sec. Sec.  52e.5(a) and 52e.5(b).</p><p class="depth0"><em>(b)</em> The notice of grant award specifies how long HHS intends to support the project without requiring the project to recompete for funds. This period, called the project period, will usually be for 1-5 years.</p><p class="depth0"><em>(c)</em> Generally, the grant will initially be for one year and subsequent continuation awards will also be for one year at a time. A grantee must submit a separate application to have the support continued for each subsequent year. Decisions regarding continuation awards and the funding level of such awards will be made after consideration of such factors as the grantee's progress and management practices, and the availability of funds. In all cases, continuation awards require a determination by HHS that continued funding is in the best interest of the government.</p><p class="depth0"><em>(d)</em> Neither the approval of any application nor the award of any grant commits or obligates the United States in any way to make any additional, supplemental, continuation, or other award with respect to any approved application or portion of an approved application.</p><p class="depth0"><em>(e)</em> Any funds granted under this part shall be expended solely for the purposes for which the funds were granted in accordance with the approved application and budget, the regulations of this part, the terms, and conditions of the award, and the applicable cost principles prescribed in subpart Q of 45 CFR part 74.
[45 FR 12249, Feb. 25, 1980, as amended at 58 FR 54298, Oct. 21, 1993]


Sec.  52e.7  What are the terms and conditions of awards?</p><p class="depth0"><em>(a)</em> Any funds granted pursuant to this part shall be expended solely for the purposes for which the funds were granted in accordance with the approved application and budget, the regulations of this part, the terms and conditions of the award, and the applicable cost principles prescribed by subpart Q of 45 CFR part 74.</p><p class="depth0"><em>(b)</em> The Director may permit unobligated grant funds remaining in the grant account at the close of a budget period to be carried forward for obligation during a subsequent budget period, provided a continuation award is made for that period and the NHLBI Director's written approval is obtained. The amount of any subsequent award will take into consideration unobligated grant funds remaining in the grant account.
[45 FR 12249, Feb. 25, 1980, as amended at 58 FR 54298, 54299, Oct. 21, 1993]


Sec.  52e.8  Other HHS regulations and policies that apply.</p><p class="depth0">Several other regulations apply to grants under this part. These include but are not necessarily limited to:
42 CFR part 50, subpart A--Responsibility of PHS awardee and applicant institutions for dealing with and reporting possible misconduct in science42 CFR part 50, subpart D--Public Health Service grant appeals procedure45 CFR part 16--Procedures of the Departmental Grant Appeals Board45 CFR part 46--Protection of human subjects

45 CFR part 74--Administration of grants45 CFR part 75--Informal grant appeals procedures45 CFR part 76--Governmentwide debarment and suspension (nonprocurement) and governmentwide requirements for drug-free workplace (grants)45 CFR part 80--Nondiscrimination under programs receiving Federal assistance through the Department of Health and Human Services--Effectuation of Title VI of the Civil Rights Act of 196445 CFR part 81--Practice and procedure for hearings under part 80 of this title45 CFR part 84--Nondiscrimination on the basis of handicap in programs and activities receiving or benefiting from Federal financial assistance45 CFR part 86--Nondiscrimination on the basis of sex in education programs and activities receiving or benefiting from Federal financial assistance45 CFR part 91--Nondiscrimination on the basis of age in HHS programs or activities receiving Federal financial assistance45 CFR part 92--Uniform administrative requirements for grants and cooperative agreements to State and local governments45 CFR part 93--New restrictions on lobbying51 FR 16958 or successor--NIH Guidelines for Research Involving Recombinant DNA Molecules``Public Health Service Policy on Humane Care and Use of Laboratory Animals,'' Office for Protection from Research Risks, NIH (Revised September 1986), or successor59 FR 14508 (as republished March 28, 1994), as may be amended, or its successor--NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research.
[58 FR 54298, Oct. 21, 1993, as amended at 59 FR 59372, Nov. 17, 1994]


Sec.  52e.9  Additional conditions.</p><p class="depth0">The Director, may with respect to any grant award impose additional conditions prior to or at the time of any award when in the Director's judgment those conditions are necessary to assure or protect advancement of the approved project, the interests of the public health, or the conservation of grant funds.
[45 FR 12249, Feb. 25, 1980, as amended at 58 FR 54299, Oct. 21, 1993]


PART 52h_SCIENTIFIC PEER REVIEW OF RESEARCH GRANT APPLICATIONS AND RESEARCH AND DEVELOPMENT CONTRACT PROJECTS--Table of Contents


Sec.52h.1 Applicability.52h.2 Definitions.52h.3 Establishment and operation of peer review groups.52h.4 Composition of peer review groups.52h.5 Conflict of interest.52h.6 Availability of information.52h.7 What matters must be reviewed for grants?52h.8 What are the review criteria for grants?52h.9 What matters must be reviewed for unsolicited contract proposals?52h.10 What matters must be reviewed for solicited contract proposals?52h.11 What are the review criteria for contract projects and proposals?52h.12 Other regulations that apply.</p><p class="depth0">Authority: 42 U.S.C. 216; 42 U.S.C. 282 (b)(6); 42 U.S.C. 284 (c)(3); 42 U.S.C. 289a.</p><p class="depth0">Source: 69 FR 275, Jan. 5, 2004, unless otherwise noted.


Sec.  52h.1  Applicability.</p><p class="depth0"><em>(a)</em> This part applies to:</p><p class="depth0"><em>(1)</em> Applications of the National Institutes of Health for grants or cooperative agreements (a reference in this part to grants includes cooperative agreements) for biomedical and behavioral research; and</p><p class="depth0"><em>(2)</em> Biomedical and behavioral research and development contract project concepts and proposals for contract projects administered by the National Institutes of Health.</p><p class="depth0"><em>(b)</em> This part does not apply to applications for:</p><p class="depth0"><em>(1)</em> Continuation funding for budget periods within an approved project period;</p><p class="depth0"><em>(2)</em> Supplemental funding to meet increased administrative costs within a project period; or</p><p class="depth0"><em>(3)</em> Construction grants.


Sec.  52h.2  Definitions.</p><p class="depth0">As used in this part:</p><p class="depth0"><em>(a)</em> Act means the Public Health Service Act, as amended (42 U.S.C. 201 et seq.).</p><p class="depth0"><em>(b)</em> Appearance of a conflict of interest means that a reviewer or close relative

or professional associate of the reviewer has a financial or other interest in an application or proposal that is known to the reviewer or the government official managing the review and would cause a reasonable person to question the reviewer's impartiality if he or she were to participate in the review; the government official managing the review (the Scientific Review Administrator or equivalent) will evaluate the appearance of a conflict of interest and determine, in accordance with this subpart, whether or not the interest would likely bias the reviewer's evaluation of the application or proposal.</p><p class="depth0"><em>(c)</em> Awarding official means the Secretary of Health and Human Services and any other officer or employee of the Department of Health and Human Services to whom the authority involved has been delegated; except that, where the Act specifically authorizes another official to make awards in connection with a particular program, the awarding official shall mean that official and any other officer or employee of the Department of Health and Human Services to whom the authority involved has been delegated.</p><p class="depth0"><em>(d)</em> Budget period means the interval of time (usually 12 months) into which the project period is divided for budgetary and reporting purposes.</p><p class="depth0"><em>(e)</em> Close relative means a parent, spouse, domestic partner, or son or daughter.</p><p class="depth0"><em>(f)</em> Contract proposal means a written offer to enter into a contract that is submitted to the appropriate agency official by an individual or nonfederal organization which includes, at a minimum, a description of the nature, purpose, duration, and cost of the project, and the methods, personnel, and facilities to be utilized in carrying it out. A contract proposal may be unsolicited by the federal government or submitted in response to a request for proposals.</p><p class="depth0"><em>(g)</em> Development means the systematic use of knowledge gained from research to create useful materials, devices, systems, or methods.</p><p class="depth0"><em>(h)</em> DHHS means the Department of Health and Human Services.</p><p class="depth0"><em>(i)</em> Director means the Director of the National Institutes of Health and any other official or employee of the National Institutes of Health to whom the authority involved has been delegated.</p><p class="depth0"><em>(j)</em> Grant as used in this part, includes cooperative agreements.</p><p class="depth0"><em>(k)</em> Peer review group means a group of primarily nongovernment experts qualified by training and experience in particular scientific or technical fields, or as authorities knowledgeable in the various disciplines and fields related to the scientific areas under review, to give expert advice on the scientific and technical merit of grant applications or contract proposals, or the concept of contract projects, in accordance with this part.</p><p class="depth0"><em>(l)</em> Principal investigator has the same meaning as in 42 CFR part 52.</p><p class="depth0"><em>(m)</em> Professional associate means any colleague, scientific mentor, or student with whom the peer reviewer is currently conducting research or other significant professional activities or with whom the member has conducted such activities within three years of the date of the review.</p><p class="depth0"><em>(n)</em> Project approach means the methodology to be followed and the resources needed in carrying out the project.</p><p class="depth0"><em>(o)</em> Project concept means the basic purpose, scope, and objectives of the project.</p><p class="depth0"><em>(p)</em> Project period has the same meaning as in 42 CFR part 52.</p><p class="depth0"><em>(q)</em> Real conflict of interest means a reviewer or a close relative or professional associate of the reviewer has a financial or other interest in an application or proposal that is known to the reviewer and is likely to bias the reviewer's evaluation of that application or proposal as determined by the government official managing the review (the Scientific Review Administrator, or equivalent), as acknowledged by the reviewer, or as prescribed by this part. A reviewer shall have a real conflict of interest if he/she or a close relative or professional associate of the reviewer:</p><p class="depth0"><em>(1)</em> Has received or could receive a direct financial benefit of any amount deriving from an application or proposal under review;</p><p class="depth0"><em>(2)</em> Apart from any direct financial benefit deriving from an application or proposal under review, has received or could receive a financial benefit from

the applicant institution, offeror or principal investigator that in the aggregate exceeds $10,000 per year; this amount includes honoraria, fees, stock or other financial benefit, and additionally includes the current value of the reviewer's already existing stock holdings. The Director, NIH, may amend the dollar threshold periodically, as appropriate, after public notice and comment; or</p><p class="depth0"><em>(3)</em> Has any other interest in the application or proposal that is likely to bias the reviewer's evaluation of that application or proposal. Regardless of the level of financial involvement or other interest, if the reviewer feels unable to provide objective advice, he/she must recuse him/herself from the review of the application or proposal at issue. The peer review system relies on the professionalism of each reviewer to identify to the designated government official any real or apparent conflicts of interest that are likely to bias the reviewer's evaluation of an application or proposal.</p><p class="depth0"><em>(r)</em> Request for proposals means a Government solicitation to prospective offerors, under procedures for negotiated contracts, to submit a proposal to fulfill specific agency requirements based on terms and conditions defined in the request for proposals. The request for proposals contains information sufficient to enable all offerors to prepare proposals, and is as complete as possible with respect to: nature of work to be performed; descriptions and specifications of items to be delivered; performance schedule; special requirements clauses, or other circumstances affecting the contract; format for cost proposals; and evaluation criteria by which the proposals will be evaluated.</p><p class="depth0"><em>(s)</em> Research has the same meaning as in 42 CFR part 52.</p><p class="depth0"><em>(t)</em> Research and development contract project means an identified, circumscribed activity, involving a single contract or two or more similar, related, or interdependent contracts, intended and designed to acquire new or fuller knowledge and understanding in the areas of biomedical or behavioral research and/or to use such knowledge and understanding to develop useful materials, devices, systems, or methods.</p><p class="depth0"><em>(u)</em> Scientific review group has the same meaning as peer review group, which is defined in paragraph (k) of this section.</p><p class="depth0"><em>(v)</em> Solicited contract proposal has the same meaning as the definition of offer in 48 CFR 2.101.</p><p class="depth0"><em>(w)</em> Unsolicited contract proposal has the same meaning as unsolicited proposal in 48 CFR 15.601.


Sec.  52h.3  Establishment and operation of peer review groups.</p><p class="depth0"><em>(a)</em> To the extent applicable, the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2) and chapter 9 of the DHHS General Administration Manual \1\ shall govern the establishment and operation of peer review groups.---------------------------------------------------------------------------</p><p class="depth0">\1\ The DHHS General Administration Manual is available for public inspection and copying at the Department's information centers listed in 45 CFR 5.31 and may be purchased from the Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402.---------------------------------------------------------------------------</p><p class="depth0"><em>(b)</em> Subject to Sec.  52h.5 and paragraph (a) of this section, the Director will adopt procedures for the conduct of reviews and the formulation of recommendations under Sec. Sec.  52h.7, 52h.9, and 52h.10.


Sec.  52h.4  Composition of peer review groups.</p><p class="depth0"><em>(a)</em> To the extent applicable, the selection and appointment of members of peer review groups and their terms of service shall be governed by chapter 9 of the DHHS General Administration Manual.</p><p class="depth0"><em>(b)</em> Subject to paragraph (a) of this section, members will be selected based upon their training and experience in relevant scientific or technical fields, or upon their qualifications as authorities knowledgeable in the various disciplines and fields related to the scientific areas under review, taking into account, among other factors:</p><p class="depth0"><em>(1)</em> The level of formal scientific or technical education completed or experience acquired by the individual;</p><p class="depth0"><em>(2)</em> The extent to which the individual has engaged in relevant research, the capacities (e.g., principal investigator, assistant) in which the

individual has done so, and the quality of the research;</p><p class="depth0"><em>(3)</em> Recognition as reflected by awards and other honors received from scientific and professional organizations; and</p><p class="depth0"><em>(4)</em> The need for the group to have included within its membership experts from various areas of specialization within relevant scientific or technical fields, or authorities knowledgeable in the various disciplines and fields related to the scientific areas under review.</p><p class="depth0"><em>(c)</em> Except as otherwise provided by law, not more than one-fourth of the members of any peer review group to which this part applies may be officers or employees of the United States. Being a member of a scientific peer review group does not make an individual an officer or employee of the United States.


Sec.  52h.5  Conflict of interest.</p><p class="depth0"><em>(a)</em> This section applies only to conflicts of interest involving members of peer review groups. This section does not cover individuals serving on National Advisory Councils or Boards, Boards of Scientific Counselors, or Program Advisory Committees who, if not already officers or employees of the United States, are special Government employees and covered by title 18 of the United States Code, the Office of Government Ethics Standards of Ethical Conduct for Employees of the Executive Branch (5 CFR part 2635), and Executive Order 11222, as amended. For those federal employees serving on peer review groups, in accordance with Sec.  52h.4, the requirements of title 18 of the United States Code, 5 CFR part 2635 and Executive Order 12674, as modified by Executive Order 12731, apply.</p><p class="depth0"><em>(b)</em> A reviewer with a real conflict of interest must recuse him/herself from the review of the application or proposal, except as otherwise provided in this section.</p><p class="depth0"><em>(1)</em> A reviewer who is a salaried employee, whether full-time or part-time, of the applicant institution, offeror, or principal investigator, or is negotiating for employment, shall be considered to have a real conflict of interest with regard to an application/proposal from that organization or principal investigator, except that the Director may determine there is no real conflict of interest or an appearance of a conflict of interest where the components of a large or multicomponent organization are sufficiently independent to constitute, in effect, separate organizations, provided that the reviewer has no responsibilities at the institution that would significantly affect the other component.</p><p class="depth0"><em>(2)</em> Where a reviewer's real conflict of interest is based upon the financial or other interest of a close relative or professional associate of the reviewer, that reviewer must recuse him/herself, unless the Director provides a waiver in accordance with paragraph (b)(4) of this section.</p><p class="depth0"><em>(3)</em> For contract proposal reviews, an individual with a real conflict of interest in a particular proposal(s) is generally not permitted to participate in the review of any proposals responding to the same request for proposals. However, if there is no other qualified reviewer available having that individual's expertise and that expertise is essential to ensure a competent and fair review, a waiver may be granted by the Director to permit that individual to serve as a reviewer of those proposals with which the reviewer has no conflict, while recusing him/herself from the review of any particular proposal(s) in which there is a conflict of interest.</p><p class="depth0"><em>(4)</em> The Director may waive any of the requirements in paragraph (b) of this section relating to a real conflict of interest if the Director determines that there are no other practical means for securing appropriate expert advice on a particular grant or cooperative agreement application, contract project, or contract proposal, and that the real conflict of interest is not so substantial as to be likely to affect the integrity of the advice to be provided by the reviewer.</p><p class="depth0"><em>(c)</em> Any appearance of a conflict of interest will result in recusal of the reviewer, unless the Director provides a waiver, determining that it would be difficult or impractical to carry out the review otherwise, and the integrity of the review process would not be impaired by the reviewer's participation.</p><p class="depth0"><em>(d)</em> When a peer review group meets regularly it is assumed that a relationship among individual reviewers in the group exists and that the group as a whole may not be objective about evaluating the work of one of its members. In such a case, a member's application or proposal shall be reviewed by another qualified review group to ensure that a competent and objective review is obtained.</p><p class="depth0"><em>(e)</em> When a member of a peer review group participates in or is present during the concept review of a contract proposal that occurs after release of the solicitation, as described under Sec.  52h.10(b), but before receipt of proposals, the member is not considered to have a real conflict of interest as described in paragraph (b) of this section, but is subject to paragraph (c) of this section concerning appearance of conflict of interest if the member is planning to respond to the solicitation. When the concept review occurs after receipt of proposals, paragraph (b) applies.</p><p class="depth0"><em>(f)</em> No member of a peer review group may participate in any review of a specific grant application or contract project for which the member has had or is expected to have any other responsibility or involvement (whether pre-award or post-award) as an officer or employee of the United States.</p><p class="depth0"><em>(g)</em> The Director may periodically issue guidance to the government officials responsible for managing reviews and reviewers on what interests would constitute a real conflict of interest or an appearance of a conflict of interest.


Sec.  52h.6  Availability of information.</p><p class="depth0"><em>(a)</em> Transcripts, minutes, and other documents made available to or prepared for or by a peer review group will be available for public inspection and copying to the extent provided by the Freedom of Information Act, as amended (5 U.S.C. 552), the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), the Privacy Act of 1974, as amended (5 U.S.C. 552a), and implementing DHHS regulations (45 CFR parts 5, 5b).</p><p class="depth0"><em>(b)</em> Meetings of peer review groups reviewing grant applications or contract proposals are closed to the public in accordance with sections 552b(c)(4) and 552b(c)(6) of the Government in the Sunshine Act, as amended (5 U.S.C. 552b(c)(4) and 552b(c)(6)) and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2). Documents made available to, or prepared for or by peer review groups that contain trade secrets or commercial or financial information obtained from a person that is privileged or confidential, and personal information concerning individuals associated with applications or proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy, are exempt from disclosure in accordance with the Freedom of Information Act, as amended (5 U.S.C. 552(b)(4) and 552(b)(6)).</p><p class="depth0"><em>(c)</em> Meetings of peer review groups reviewing contract project concepts are open to the public in accordance with the provisions of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2) and the Government in the Sunshine Act, as amended (5 U.S.C. 552b).


Sec.  52h.7  What matters must be reviewed for grants?</p><p class="depth0"><em>(a)</em> Except as otherwise provided by law, no awarding official shall award a grant based upon an application covered by this part unless the application has been reviewed by a peer review group in accordance with the provisions of this part and the group has made recommendations concerning the scientific merit of that application. In addition, where under applicable law an awarding official is required to secure the approval or advice of a national council or board concerning an application, the application may not be considered by the council or board unless it has been reviewed by the appropriate peer review group, in accordance with the provisions of this part, and the group has made recommendations concerning the scientific merit of the application, except where the council or board is the peer review group.</p><p class="depth0"><em>(b)</em> Except to the extent otherwise provided by law, recommendations by peer review groups are advisory only and not binding on the awarding official or the national advisory council or board.



Sec.  52h.8  What are the review criteria for grants?</p><p class="depth0">In carrying out its review under Sec.  52h.7, the scientific peer review group shall assess the overall impact that the project could have on the research field involved, taking into account, among other pertinent factors:</p><p class="depth0"><em>(a)</em> The significance of the goals of the proposed research, from a scientific or technical standpoint;</p><p class="depth0"><em>(b)</em> The adequacy of the approach and methodology proposed to carry out the research;</p><p class="depth0"><em>(c)</em> The innovativeness and originality of the proposed research;</p><p class="depth0"><em>(d)</em> The qualifications and experience of the principal investigator and proposed staff;</p><p class="depth0"><em>(e)</em> The scientific environment and reasonable availability of resources necessary to the research;</p><p class="depth0"><em>(f)</em> The adequacy of plans to include both genders, minorities, children and special populations as appropriate for the scientific goals of the research;</p><p class="depth0"><em>(g)</em> The reasonableness of the proposed budget and duration in relation to the proposed research; and</p><p class="depth0"><em>(h)</em> The adequacy of the proposed protection for humans, animals, and the environment, to the extent they may be adversely affected by the project proposed in the application.


Sec.  52h.9  What matters must be reviewed for unsolicited contractproposals?</p><p class="depth0"><em>(a)</em> Except as otherwise provided by law, no awarding official shall award a contract based upon an unsolicited contract proposal covered by this part unless the proposal has been reviewed by a peer review group in accordance with the provisions of this part and the group has made recommendations concerning the scientific merit of that proposal.</p><p class="depth0"><em>(b)</em> Except to the extent otherwise provided by law, peer review group recommendations are advisory only and not binding on the awarding official.


Sec.  52h.10  What matters must be reviewed for solicited contract proposals?</p><p class="depth0"><em>(a)</em> Subject to paragraphs (b) and (c) of this section, no awarding official shall issue a request for contract proposals with respect to a contract project involving solicited contract proposals, unless the project concept has been reviewed by a peer review group or advisory council in accordance with this part and the group has made recommendations concerning the scientific merit of the concept.</p><p class="depth0"><em>(b)</em> The awarding official may delay carrying out the requirements for peer review of paragraph (a) of this section until after issuing a request for proposals if the official determines that the accomplishment of essential program objectives would otherwise be placed in jeopardy and any further delay clearly would not be in the best interest of the Government. The awarding official shall specify in writing the grounds on which this determination is based. Under these circumstances, the awarding official will not award a contract until peer review of the project concept and the proposals has been completed. The request for proposals shall state that the project concept will be reviewed by a peer review group and that no award will be made until the review is conducted and recommendations made based on that review.</p><p class="depth0"><em>(c)</em> The awarding official may determine that peer review of the project concept for behavioral or biomedical research and development contracts is not needed if one of the following circumstances applies: the solicitation is to re-compete or extend a project that is within the scope of a current project that has been peer reviewed, or there is a Congressional authorization or mandate to conduct specific contract projects. If a substantial amount of time has passed since the concept review, the awarding official shall determine whether peer review is required to ensure the continued scientific merit of the concept.</p><p class="depth0"><em>(d)</em> Except to the extent otherwise provided by law, the recommendations referred to in this section are advisory only and not binding on the awarding official.


Sec.  52h.11  What are the review criteria for contract projects and proposals?</p><p class="depth0"><em>(a)</em> In carrying out its review of a project concept under Sec.  52h.10(a) or Sec.  52h.10(b), the peer review group shall

take into account, among other pertinent factors:</p><p class="depth0"><em>(1)</em> The significance from a scientific or technical standpoint of the goals of the proposed research or development activity;</p><p class="depth0"><em>(2)</em> The availability of the technology and other resources necessary to achieve those goals;</p><p class="depth0"><em>(3)</em> The extent to which there are identified, practical uses for the anticipated results of the activity; and</p><p class="depth0"><em>(4)</em> Where the review includes the project approach, the adequacy of the methodology to be utilized in carrying out the activity.</p><p class="depth0"><em>(b)</em> In carrying out its review of unsolicited contract proposals under Sec.  52h.9, the peer review group shall take into account, among other pertinent factors, the criteria in Sec.  52h.8 which are relevant to the particular proposals.</p><p class="depth0"><em>(c)</em> In carrying out its review of solicited proposals under Sec.  52h.10(a) or (b), the peer review group shall evaluate each proposal in accordance with the criteria set forth in the request for proposals.


Sec.  52h.12  Other regulations that apply.</p><p class="depth0">The regulations in this part are in addition to, and do not supersede other regulations concerning grant applications, contract projects, or contract proposals set forth elsewhere in this title, title 45, or title 48 of the Code of Federal Regulations.


PART 52i_NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH ENDOWMENT PROGRAMS (Eff. 10-8-15)--Table of Contents


Sec.52i.1 To what programs does this part apply?52i.2 Definitions.52i.3 Who is eligible to apply?52i.4 Under what conditions may an eligible institution designate a</p><p class="depth0">foundation as the recipient of a research endowment grant?52i.5 How to apply for a grant.52i.6 Evaluation and disposition of research endowment grant</p><p class="depth0">applications.52i.7 Grant Awards.52i.8 When and for what purposes may a grantee spend the endowment fund</p><p class="depth0">corpus?52i.9 How much endowment fund income may a grantee spend and for what</p><p class="depth0">purposes?52i.10 How shall a grantee calculate the amount of endowment fund income</p><p class="depth0">that it may withdraw and spend?52i.11 What shall a grantee record and report?52i.12 What happens if a grantee fails to administer the research</p><p class="depth0">endowment grant in accordance with applicable regulations?52i.13 Other HHS policies and regulations that apply.52i.14 Additional conditions.</p><p class="depth0">Authority: 42 U.S.C. 216, 285t-285t-1.</p><p class="depth0">Source: 80 FR 53744, Sept. 8, 2015, unless otherwise noted.</p><p class="depth0">Effective Date Note: At 80 FR 53744, Sept. 8, 2015, part 52i was added, effective Oct. 8, 2015.


Sec.  52i.1  To what programs does this part apply?</p><p class="depth0">This part applies to grants awarded under section 464z-3(h) of the Public Health Service Act (the Act), which authorizes the Director of the National Institute on Minority Health and Health Disparities (NIMHD) to carry out a program of research endowment grants to eligible institutions to facilitate minority health and health disparities research (the NIMHD Research Endowment Program), and, with the exception of Sec. Sec.  52i.5 and 52i.6, applies to that portion of an award made under section 464z-4(f) of the Act authorized by the NIMHD Director for research endowment.


Sec.  52i.2  Definitions.</p><p class="depth0">As used in this part:</p><p class="depth0">Act means the Public Health Service Act, as amended (42 U.S.C. 201 et seq.).</p><p class="depth0">Center of Excellence means, for purposes of grants authorized by section 464z-3(h) of the Act, an institution designated as a Center of Excellence and receiving a grant under section 736 (42 U.S.C. 293) or section 464z-4 (42 U.S.C. 285t-1) of the Act.</p><p class="depth0">Director means the Director, NIMHD, of the National Institutes of Health.</p><p class="depth0">Endowment fund means a fund that is established by state law, by an institution, or by a foundation associated with an institution that is exempt from taxation and is maintained for the purpose of generating income for the support of minority and health disparities research or research training if the funds are from a grant made under

section 464z-3 of the Act. The principal or corpus of the fund may not be spent except as noted in Sec.  52i.8(b).</p><p class="depth0">Endowment fund corpus means an amount equal to the total grant funds awarded under this part or equal to the amount designated as endowment under section 464z-4 of the Act.</p><p class="depth0">Endowment fund income means the income generated from investing the corpus, i.e., the amount of which exceeds the endowment fund corpus.</p><p class="depth0">Health disparities research means basic, clinical, and behavioral research on health disparity populations (including individual members and communities of such populations) that relates to health disparities, including the causes of such disparities and methods to prevent, diagnose, and treat such disparities.</p><p class="depth0">Health disparity population means a population that, as determined by the Director of the NIMHD after consultation with the Director of the Agency for Healthcare Research and Quality, has a significant disparity in the overall rate of disease incidence, prevalence, morbidity, mortality, or survival rates in the population as compared to the health status of the general population.</p><p class="depth0">Health disparity students means students of minority health disparity populations or other health disparities populations.</p><p class="depth0">Institutional endowment (IE) means the corporate or system-wide endowment fund that is the sum total of the endowment assets of all campuses and their components. This includes, but is not limited to, endowments managed by an institution's foundations/associations as well as state university systems.</p><p class="depth0">Institution system-wide means all campuses and components.</p><p class="depth0">Minority health conditions means, with respect to individuals who are members of minority groups, all diseases, disorders, and conditions (including with respect to mental health and substance abuse):</p><p class="depth0"><em>(1)</em> Unique to, more serious, or more prevalent in such individuals;</p><p class="depth0"><em>(2)</em> For which the factors of medical risk or types of medical intervention may be different for such individuals, or for which it is unknown whether such factors or types are different for such individuals; or</p><p class="depth0"><em>(3)</em> With respect to which there has been insufficient research involving such individuals as subjects or insufficient data on such individuals.</p><p class="depth0">Minority health disparities research means basic, clinical, and behavioral research on minority health conditions, including research to prevent, diagnose, and treat such conditions.</p><p class="depth0">Racial and ethnic minority or minority group means American Indians (including Alaska Natives, Eskimos, and Aleuts), Asian Americans, Native Hawaiians and other Pacific Islanders, Blacks, and Hispanics. Hispanic means individuals whose origin is Mexican, Puerto Rican, Cuban, Central or South American, or other Spanish culture or origin.</p><p class="depth0">Secretary means the Secretary of Health and Human Services and any other officer or employee of the Department of Health and Human Services to whom the authority involved has been delegated.


Sec.  52i.3  Who is eligible to apply?</p><p class="depth0"><em>(a)</em> To be eligible for a grant under section 464z-3(h) of the Act an applicant:</p><p class="depth0"><em>(1)</em> Must be a Center of Excellence under section 736 (42 U.S.C. 293) or section 464z-4 (42 U.S.C. 285t-1) of the Act, and</p><p class="depth0"><em>(2)</em> Must have an institutional endowment that is equal to or less than 50 percent of the national median of endowment funds at institutions that conduct similar biomedical research and training of health professionals.</p><p class="depth0"><em>(b)</em> To be eligible for a portion of a grant award to be expended as a research endowment under section 464z-4(f) of the Act, an applicant:</p><p class="depth0"><em>(1)</em> Must be a designated biomedical and behavioral research institution under section 464z-4 of the Act, and</p><p class="depth0"><em>(2)</em> Must submit those materials prescribed by the Director, NIMHD.


Sec.  52i.4  Under what conditions may an eligible institution designate a foundation as the recipient of a research endowment grant?</p><p class="depth0">A number of universities and other organizations have established closely affiliated, but separately incorporated,

organizations to facilitate the administration of research and other programs supported by federal funds. Such legally independent entities are often referred to as ``foundations,'' although this term does not necessarily appear in the name of the organization. An institution awarded an endowment grant under section 464z-3(h) of the Act or using designated grant funds for endowment purposes under section 464z-4(f) of the Act may designate a foundation associated with the institution to receive the endowment funds only for investment purposes if:</p><p class="depth0"><em>(a)</em> The institution assures in its application that the foundation is legally authorized to receive the endowment funds and to administer the endowment funds in accordance with the regulations set forth in this part;</p><p class="depth0"><em>(b)</em> The foundation agrees to administer the endowment funds in accordance with the regulations in this part;</p><p class="depth0"><em>(c)</em> The institution agrees to be liable for any violation by the foundation of any applicable regulation, including any violation resulting in monetary liability; and</p><p class="depth0"><em>(d)</em> The grantee institution has control and is responsible for the administration of the grant accounts.


Sec.  52i.5  How to apply for a grant.</p><p class="depth0"><em>(a)</em> Each institution interested in applying for a grant under section 464z-3(h) of the Act must submit an application at such time and in such form and manner as the Secretary may prescribe.</p><p class="depth0"><em>(b)</em> An institution described in Sec.  52i.3 that has received a grant under this part may apply for another grant under this part if:</p><p class="depth0"><em>(1)(i)</em> The institution still meets the eligibility requirements in Sec.  52i.3; and</p><p class="depth0"><em>(i)</em> The institution still meets the eligibility requirements in Sec.  52i.3; and</p><p class="depth0"><em>(ii)</em> The institution is in the last year of funding provided by NIH under this part; or</p><p class="depth0"><em>(2)</em> The institution no longer has an active grant under this part from NIH.


Sec.  52i.6  Evaluation and award of research endowment grant applications.</p><p class="depth0">All applications filed in accordance with this part and meeting the minimal eligibility requirements shall be evaluated and recommended by technical and scientific peer review. The review evaluation shall take into account, among other pertinent factors:</p><p class="depth0"><em>(a)</em> The scientific and technical merit of the proposed project to facilitate minority health disparities research and other health disparities research;</p><p class="depth0"><em>(b)</em> The likelihood of its producing meaningful results;</p><p class="depth0"><em>(c)</em> The adequacy of the applicant's resources available for the project; and</p><p class="depth0"><em>(d)</em> The adequacy of the applicant's plan for managing the endowment fund.


Sec.  52i.7  Grant awards.</p><p class="depth0"><em>(a)</em> Within the limits of funds, and upon such review and recommendation as may be required by law, the Director shall award a grant to those applicants whose approved projects will in the Director's judgment best promote the purposes of this part.</p><p class="depth0"><em>(b)</em> An institution described in Sec.  52i.3 that receives a grant under this part or an institution described in section 464z-4(f) of the Act authorized to use grant funds for endowment purposes shall follow the spending rules under the law of the state in which the institution is located and the spending rules/policies adopted by the recipient institution, provided that such spending rules are not inconsistent with applicable federal regulations/policies.</p><p class="depth0"><em>(c)</em> Grants awarded under this part or grant funds designated for endowment purposes as described under section 464z-4(f) of the Act must be invested no later than 90 days after the start date of the grant.</p><p class="depth0"><em>(d)</em> The institution, in investing the endowment fund established under this section, shall exercise the judgment and care, under the circumstances then prevailing, that a person of prudence, discretion, and intelligence would exercise in the management of such person's own affairs and avoid all appearances of conflict of interest in the management of this fund.</p><p class="depth0"><em>(e)</em> The total amount of an endowment grant under this part or the designated amount of the grant under section 464z-4(f) of the Act must be maintained as corpus by the institution for 20 years from the end of the project period.</p><p class="depth0"><em>(f)</em> In the case of situations in which investment conditions result in the corpus referred to in paragraph (e) of this section having a net market value less than the value of the funds at the time of their receipt, appropriate actions must be taken (e.g., careful review of the investment strategy) in order to preserve the value of the endowment corpus.</p><p class="depth0"><em>(g)</em> An institution described in Sec.  52i.3 receiving an endowment grant under section 464z-3(h) of the Act may not simultaneously receive endowment funds under section 464z-4(f) of the Act.</p><p class="depth0"><em>(h)</em> Consistent with section 464z-4(f) of the Act, the Director, NIMHD, may designate for a research endowment some of the funds awarded to a Center of Excellence for research education and training.


Sec.  52i.8  When and for what purposes may a grantee spend the endowment fund corpus?</p><p class="depth0"><em>(a)</em> A grantee may not withdraw or spend any part of the endowment fund corpus for a total of 20 years from the end of the project period.</p><p class="depth0"><em>(b)</em> At the end of the 20-year period, during which the endowment corpus must be maintained, the grantee institution is encouraged to preserve the endowment fund corpus but may use the endowment fund corpus for any purpose that expands or develops the institution's minority health and/or health disparities research and/or training capacity.


Sec.  52i.9  How much endowment fund income may a grantee spend and for what purposes?</p><p class="depth0"><em>(a)</em> Any endowment income realized in the initial year following the grant award under this part shall not be expended to support programmatic activities until after conclusion of the initial year of the grant.</p><p class="depth0"><em>(b)</em> After the first year of the grant, a grantee awarded funds under this part may spend endowment income realized from funds it receives solely in accordance with the regulations of this part, the terms and conditions of the award, NIMHD policies and procedures, and the grantee's strategic plan that has been approved by the NIMHD and includes priorities for the use of the endowment fund income.


Sec.  52i.10  How shall a grantee calculate the amount of endowment fund income that it may withdraw and spend?</p><p class="depth0">A grantee awarded funds under this part shall calculate the amount of endowment fund income that it may withdraw and spend at a particular time as follows:</p><p class="depth0"><em>(a)</em> On each date that the grantee plans a withdrawal of endowment fund income, the grantee must determine the amount of the income by calculating the value of the fund that exceeds the endowment fund corpus.</p><p class="depth0"><em>(b)</em> If the total value of the endowment fund exceeds the endowment fund corpus, the grantee may withdraw and spend the excess amount, i.e., the endowment fund income, in accordance with Sec.  52i.9.


Sec.  52i.11  What shall a grantee record and report?</p><p class="depth0">A grantee awarded funds under this part shall:</p><p class="depth0"><em>(a)</em> Maintain appropriate records in compliance with this part and other requirements as referenced in terms of the award, including documentation of:</p><p class="depth0"><em>(1)</em> The type and amount of investments of the endowment fund;</p><p class="depth0"><em>(2)</em> The amount of endowment fund income and corpus;</p><p class="depth0"><em>(3)</em> The amount and purpose of expenditures of endowment fund income; and</p><p class="depth0"><em>(4)</em> The expenses and charges associated with the management of the endowment funds if such expenses and charges were paid from endowment fund income.</p><p class="depth0"><em>(b)</em> Retain records in accordance with 45 CFR 74.53. The endowment fund corpus, fund income, and fund expenditures must be reported over a 20-year period, and supporting records are to be retained for 3 years after the submission of the final report to the NIMHD;</p><p class="depth0"><em>(c)</em> Permit authorized officials the authority to conduct a review, as set forth in 45 CFR 74.53(e) (which states that the Department of Health and Human Services (HHS) awarding agencies, the HHS Inspector General, the U.S. Comptroller General, and any of

their duly authorized representatives ``have the right of timely and unrestricted access to any books, documents, papers, or other records of recipients that are pertinent to the awards, in order to make audits, examinations, excerpts, transcripts, or copies of such documents''); and</p><p class="depth0"><em>(d)</em> Submit Financial Status Reports, as set forth in 45 CFR 74.52, as required by the NIMHD and in the form prescribed. A final Financial Status Report shall be required 20 years after the end of the project period.


Sec.  52i.12  What happens if a grantee fails to administer the research endowment grant in accordance with applicable regulations?</p><p class="depth0"><em>(a)</em> The Director, after giving notice and an opportunity for a hearing, may authorize the termination of a grant awarded and/or recovery of funds under this part during the 20-year period if the grantee:</p><p class="depth0"><em>(1)</em> Withdraws or spends any part of the endowment fund corpus in violation of this part;</p><p class="depth0"><em>(2)</em> Spends any portion of the endowment fund income not permitted to be spent in this part;</p><p class="depth0"><em>(3)</em> Fails to invest the endowment fund corpus in accordance with the investment standards set forth in this part;</p><p class="depth0"><em>(4)</em> Fails to meet the requirements in Sec.  52i.7; or</p><p class="depth0"><em>(5)</em> Otherwise fails to comply with the terms and conditions of the award.</p><p class="depth0"><em>(b)</em> Recovery of funds may include up to the amount of endowment awards plus any income earned.


Sec.  52i.13  Other HHS policies and regulations that apply.</p><p class="depth0">Several other regulations and policies apply to grants under this part. These include, but are not limited to:</p><p class="depth0"><em>(a)</em> 2 CFR part 376--HHS Nonprocurement debarment and suspension.</p><p class="depth0"><em>(b)</em> 42 CFR part 50, subpart D--Public Health Service grant appeals procedure.</p><p class="depth0"><em>(c)</em> 42 CFR part 93--Public Health Service policies on research misconduct.</p><p class="depth0"><em>(d)</em> 45 CFR part 16--Procedures of the Departmental Grant Appeals Board.</p><p class="depth0"><em>(e)</em> 45 CFR part 46--Protection of human subjects.</p><p class="depth0"><em>(f)</em> 45 CFR part 74--Uniform administrative requirements for awards and subawards to institutions of higher education, hospitals, other nonprofit organizations, and commercial organizations; and certain grants and agreements with states, local governments, and Indian tribal governments.</p><p class="depth0"><em>(g)</em> 45 CFR part 80--Nondiscrimination under programs receiving federal assistance through the Department of Health and Human Services effectuation of Title VI of the Civil Rights Act of 1964.</p><p class="depth0"><em>(h)</em> 45 CFR part 81--Practice and procedure for hearings under part 80 of this chapter.</p><p class="depth0"><em>(i)</em> 2 CFR part 382--Requirements for drug-free workplace (financial assistance).</p><p class="depth0"><em>(j)</em> 45 CFR part 84--Nondiscrimination on the basis of handicap in programs or activities receiving federal financial assistance.</p><p class="depth0"><em>(k)</em> 45 CFR part 86--Nondiscrimination on the basis of sex in education programs or activities receiving federal financial assistance.</p><p class="depth0"><em>(l)</em> 45 CFR part 91--Nondiscrimination on the basis of age in programs or activities receiving federal financial assistance from HHS.</p><p class="depth0"><em>(m)</em> 45 CFR part 92--Uniform administrative requirements for grants and cooperative agreements to State, local, and tribal governments.</p><p class="depth0"><em>(n)</em> 45 CFR part 93--New restrictions on lobbying.</p><p class="depth0"><em>(o)</em> NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules at http://osp.od.nih.gov/sites/default/files/NIH_Guidelines_0.pdf. Further information may be obtained from the NIH Office of Biotechnology Activities via email at OBA-OSP@od.nih.gov or the OBA Web site at http://osp.od.nih.gov/office-biotechnology-activities.</p><p class="depth0"><em>(p)</em> NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-001.html. Further information may be obtained from the NIH Office of Research on Women's Health via email at ORWHINFO@mail.nih.gov or the ORWH Web site at http://ORWH.od.nih.gov.</p><p class="depth0"><em>(q)</em> NIH Grants Policy Statement (October 1, 2013). This version is located on the NIH Web site at http://grants.nih.gov/grants/policy/nihgps_2013. [Note: this policy is subject to change, and interested persons should contact the Office of Policy for Extramural Research Administration (OPERA), Office of Extramural Research, NIH, 6701 Rockledge Drive, Suite 350, MSC 7974, Bethesda, MD 20892-7974 (telephone 301-435-0938 or toll-free 800-518-4726), to obtain references to the current version and any amendments. Information may be obtained also by contacting the OPERA Division of Grants Policy via email at GrantsPolicy@mail.nih.gov. Previous versions of the NIH Grants Policy Statement are archived at http://grants.nih.gov/grants/policy/policy.htm.]</p><p class="depth0"><em>(r)</em> Public Health Service Policy on Humane Care and Use of Laboratory Animals, Office of Laboratory Animal Welfare, NIH (Revised August 2002). [Note: this policy is subject to change, and interested persons should contact the Office of Laboratory Animal Welfare, NIH, Rockledge 1, Suite 360, MSC 7982, 6705 Rockledge Drive, Bethesda, MD 20892-7982 (telephone 301-594-2382, not a toll-free number), to obtain references to the current version and any amendments. Information may be obtained also via the OLAW Web site at http://grants.nih.gov/grants/olaw/olaw.htm.]


Sec.  52i.14  Additional conditions.</p><p class="depth0">The Director may, with respect to any grant award, impose additional conditions prior to, or at the time of, any award when in the Director's judgment the conditions are necessary to ensure the carrying out of the purposes of the award, the interests of the public health, or the conservation of grant funds.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with  by <a href="https://18f.gsa.gov/">18F</a>. Code available <a href="#">on Github.</a></h5>
      </div>
    </div>
  </footer>
  </body>
</html>
